Publications
2025
Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients.
Sarker, C., Jorgensen, A. L., Tharmaratnam, K., Al-Abadi, E., Armon, K., Bailey, K., . . . Md Smith, E. (2025). Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients.. Rheumatology (Oxford, England), keaf057. doi:10.1093/rheumatology/keaf057
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.
Sadun, R. E., Cooper, J. C., Belot, A., Avcin, T., Aggarwal, A., Ainsworth, J., . . . CARRA SLE Committee and PReS Lupus Working Party. (2025). Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.. Annals of the rheumatic diseases, 84(2), 158-168. doi:10.1136/ard-2024-226528
2024
Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis.
Tordoff, M., Smith, S. L., Lawson-Tovey, S., Dick, A. D., Beresford, M. W., Ramanan, A. V., . . . CLUSTER Consortium. (2024). Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis.. Arthritis & rheumatology (Hoboken, N.J.), 76(12), 1789-1796. doi:10.1002/art.42955
Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.
Sadun, R. E., Cooper, J. C., Belot, A., Avcin, T., Aggarwal, A., Ainsworth, J., . . . CARRA SLE Committee and PReS Lupus Working Party. (2024). Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research.. Annals of the rheumatic diseases, ard-2024-226528. doi:10.1136/ard-2024-226528
Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study.
Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Douglas, S., Foster, H. E., Southwood, T. R., . . . UK JIA Biologics Register. (2024). Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study.. The Lancet. Rheumatology, 6(7), e438-e446. doi:10.1016/s2665-9913(24)00087-0
POS0304 ALLELE COUNTS ASSOCIATE WITH EARLY DISEASE ONSET, ORGAN INVOLVEMENT AND DISEASE SEVERITY IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
Natoli, V., Charras, A., Hasoon, M., Caamano Gutierrez, E., MD Smith, E., Beresford, M. W., & Hedrich, C. M. (2024). POS0304 ALLELE COUNTS ASSOCIATE WITH EARLY DISEASE ONSET, ORGAN INVOLVEMENT AND DISEASE SEVERITY IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS. In Annals of the Rheumatic Diseases Vol. 83 (pp. 261-262). Elsevier BV. doi:10.1136/annrheumdis-2024-eular.1103
Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force.
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Marks, S. D. (2024). Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force.. Clinical immunology (Orlando, Fla.), 110214. doi:10.1016/j.clim.2024.110214
Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.
Renaudineau, Y., Charras, A., Natoli, V., Fusaro, M., Smith, E. M. D., Beresford, M. W., . . . UK jSLE Cohort Study. (2024). Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.. Clinical immunology (Orlando, Fla.), 262, 110194. doi:10.1016/j.clim.2024.110194
Development and implementation of 'A guide to PPIE - Early Integration into Research Proposals' in a multi-disciplinary consortium.
Beesley, R., Luling Feilding, F., CLUSTER Consortium Champions., Rosser, E. C., Shoop-Worrall, S. J. W., McNeece, A., . . . CLUSTER Consortium. (2024). Development and implementation of 'A guide to PPIE - Early Integration into Research Proposals' in a multi-disciplinary consortium.. Rheumatology (Oxford, England), 63(3), e88-e91. doi:10.1093/rheumatology/kead482
P2RX7 gene variants associate with altered inflammasome assembly and reduced pyroptosis in chronic nonbacterial osteomyelitis (CNO).
Charras, A., Hofmann, S. R., Cox, A., Schulze, F., Russ, S., Northey, S., . . . Hedrich, C. M. (2024). P2RX7 gene variants associate with altered inflammasome assembly and reduced pyroptosis in chronic nonbacterial osteomyelitis (CNO).. Journal of autoimmunity, 144, 103183. doi:10.1016/j.jaut.2024.103183
Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts.
Shoop-Worrall, S. J. W., Lawson-Tovey, S., Wedderburn, L. R., Hyrich, K. L., Geifman, N., & CLUSTER Consortium. (2024). Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts.. EBioMedicine, 100, 104946. doi:10.1016/j.ebiom.2023.104946
2023
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.
Md Yusof, M. Y., Smith, E. M. D., Ainsworth, S., Armon, K., Beresford, M. W., Brown, M., . . . Vital, E. M. (2023). Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.. Rheumatology advances in practice, 7(3), rkad093. doi:10.1093/rap/rkad093
Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases.
Zaripova, L. N., Midgley, A., Christmas, S. E., Beresford, M. W., Pain, C., Baildam, E. M., & Oldershaw, R. A. (2023). Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases.. International journal of molecular sciences, 24(22), 16040. doi:10.3390/ijms242216040
Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series.
Platt, C., Longthorpe, C., Sit, J., Marks, S. D., Harmer, M., Ciurtin, C., . . . UK JSLE Study Group. (2023). Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series.. Clinical and experimental rheumatology, 41(9), 1934-1939. doi:10.55563/clinexprheumatol/pye2t3
Stuck in transit: A qualitative study of the transitional care needs of young people with epilepsy and juvenile idiopathic arthritis
Wilson, N., Whittaker, K., Arnott, J., Burke, L., Beresford, M. W., & Peak, M. (2023). Stuck in transit: A qualitative study of the transitional care needs of young people with epilepsy and juvenile idiopathic arthritis. JOURNAL OF CHILD HEALTH CARE, 27(3), 435-449. doi:10.1177/13674935221074777
On the climate emergency and the health of our patients: comment on the article by Dellaripa et al
Hospach, T., Belot, A. W., Beresford, M., Dressler, F., Kallinich, T., Oommen, P. E., . . . Hedrich, C. (2023). On the climate emergency and the health of our patients: comment on the article by Dellaripa et al. ARTHRITIS & RHEUMATOLOGY, 75(8), 1493-1494. doi:10.1002/art.42483
Reporting involvement activities with children and young people in paediatric research: a framework analysis.
Preston, J., Biglino, G., Harbottle, V., Dalrymple, E., Stalford, H., & Beresford, M. W. (2023). Reporting involvement activities with children and young people in paediatric research: a framework analysis.. Research involvement and engagement, 9(1), 61. doi:10.1186/s40900-023-00477-8
Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.
Akthar, M., Nair, N., Carter, L. M., Vital, E. M., Sutton, E., McHugh, N., . . . Reynolds, J. A. (2023). Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil.. Arthritis research & therapy, 25(1), 111. doi:10.1186/s13075-023-03089-5
Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO)
Hedrich, C. M., Beresford, M. W., Dedeoglu, F., Hahn, G., Hofmann, S. R., Jansson, A. F., . . . Girschick, H. J. (2023). Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO). CLINICAL IMMUNOLOGY, 251. doi:10.1016/j.clim.2023.109344
Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. ANNALS OF THE RHEUMATIC DISEASES, 82(6), 788-798. doi:10.1136/ard-2022-223328
Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis
Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Douglas, S., Foster, H. E., Southwood, T. R., . . . Ciurtin, C. (2023). Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis. RHEUMATOLOGY, 62(5), 1926-1935. doi:10.1093/rheumatology/keac463
Urinary complement proteins are increased in children with IgA vasculitis (Henoch-Schonlein purpura) nephritis
Wright, R. D., Marro, J., Northey, S. J., Corkhill, R., Beresford, M. W., & Oni, L. (2023). Urinary complement proteins are increased in children with IgA vasculitis (Henoch-Schonlein purpura) nephritis. PEDIATRIC NEPHROLOGY, 38(5), 1491-1498. doi:10.1007/s00467-022-05747-3
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)
Smith, E. M. D., Aggarwal, A., Ainsworth, J., Al-Abadi, E., Avcin, T., Bortey, L., . . . Beresford, M. W. (2023). PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS). CLINICAL IMMUNOLOGY, 250. doi:10.1016/j.clim.2023.109296
Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE
Charras, A., Haldenby, S., Smith, E. M. D., Egbivwie, N., Olohan, L., Kenny, J. G., . . . Hedrich, C. M. (2023). Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE. RHEUMATOLOGY, 62(SI2), SI210-SI225. doi:10.1093/rheumatology/keac275
Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases.
Gavan, S. P., Bruce, I. N., Payne, K., & MASTERPLANS Consortium. (2023). Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 26(1), 115-122. doi:10.1016/j.jval.2022.07.001
2022
Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus
Smith, E. M. D., Tharmaratnam, K., Al-Abadi, E., Armon, K., Bailey, K., Brennan, M., . . . Beresford, M. W. (n.d.). Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus. Rheumatology. doi:10.1093/rheumatology/keab915
Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study
Smith, E. M. D., Egbivwie, N., Jorgensen, A. L., Ciurtin, C., Al-Abadi, E., Armon, K., . . . Hedrich, C. M. (2022). Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study. CLINICAL IMMUNOLOGY, 239. doi:10.1016/j.clim.2022.109028
What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?
Gallagher, K. L., Patel, P., Beresford, M. W., & Smith, E. M. D. (2022). What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?. FRONTIERS IN PEDIATRICS, 10. doi:10.3389/fped.2022.884634
Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study
Carlsson, E., Quist, A., Davies, J. C., Midgley, A., Smith, E. M. D., Bruce, I. N., . . . Hedrich, C. M. (2022). Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study. Clinical Immunology, 236, 108948. doi:10.1016/j.clim.2022.108948
Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland
Lythgoe, H., Smith, E. M. D., Killeen, O. G., Murphy, R., Pilkington, C., Pain, C. E., & Beresford, M. W. (2022). Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland. RHEUMATOLOGY. doi:10.1093/rheumatology/keac064
2021
Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply
Smith, E. M. D., Beresford, M. W., McCann, L., & Hedrich, C. M. (2022). Comment on: Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?: Reply. RHEUMATOLOGY, 61(1), E27-E28. doi:10.1093/rheumatology/keab667
Nothing about us without us: involving patient collaborators for machine learning applications in rheumatology.
Shoop-Worrall, S. J. W., Cresswell, K., Bolger, I., Dillon, B., Hyrich, K. L., Geifman, N., & Members of the CLUSTER consortium. (2021). Nothing about us without us: involving patient collaborators for machine learning applications in rheumatology.. Annals of the rheumatic diseases, 80(12), 1505-1510. doi:10.1136/annrheumdis-2021-220454
The clinical significance of antinuclear antibodies and specific autoantibodies in juvenile and adult systemic lupus erythematosus patients
Rodsaward, P., Chottawornsak, N., Suwanchote, S., Rachayon, M., Deekajorndech, T., Wright, H. L., . . . Chiewchengchol, D. (2021). The clinical significance of antinuclear antibodies and specific autoantibodies in juvenile and adult systemic lupus erythematosus patients. ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 39(4), 279-286. doi:10.12932/AP-211218-0465
“It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE
Smith, E. M. D., Gorst, S. L., Al-Abadi, E., Hawley, D. P., Leone, V., Pilkington, C., . . . Young, B. (n.d.). “It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE. Rheumatology. doi:10.1093/rheumatology/keab173
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study
Giani, T., Smith, E. M., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2021). Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. LUPUS, 30(12), 1955-1965. doi:10.1177/09612033211045050
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
Zaripova, L. N., Midgley, A., Christmas, S. E., Beresford, M. W., Baildam, E. M., & Oldershaw, R. A. (2021). Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. PEDIATRIC RHEUMATOLOGY, 19(1). doi:10.1186/s12969-021-00629-8
Serum protein signatures differentiate paediatric autoimmune/ inflammatory disorders
Carlsson, E., Midgley, A., Perkins, S., Caamano-Gutierrez, E., Gritzfeld, J. F., Beresford, M. W., & Hedrich, C. M. (2021). Serum protein signatures differentiate paediatric autoimmune/ inflammatory disorders. CLINICAL IMMUNOLOGY, 229. doi:10.1016/j.clim.2021.108790
Juvenile Idiopathic Arthritis Associated Uveitis
Carlsson, E., Beresford, M. W., Ramanan, A. V., Dick, A. D., & Hedrich, C. M. (2021). Juvenile Idiopathic Arthritis Associated Uveitis. CHILDREN-BASEL, 8(8). doi:10.3390/children8080646
Kidney outcomes for children with lupus nephritis
Oni, L., Wright, R. D., Marks, S., Beresford, M. W., & Tullus, K. (2021). Kidney outcomes for children with lupus nephritis. PEDIATRIC NEPHROLOGY, 36(6), 1377-1385. doi:10.1007/s00467-020-04686-1
REAL-WORLD EFFECTIVENESS OF ETANERCEPT AND ADALIMUMAB IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) WITHOUT UVEITIS
Kearsley-Fleet, L., Baildam, E., Beresford, M., Foster, H., Southwood, T., Thomson, W., & Hyrich, K. (2021). REAL-WORLD EFFECTIVENESS OF ETANERCEPT AND ADALIMUMAB IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA) WITHOUT UVEITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 927). doi:10.1136/annrheumdis-2021-eular.186
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK
Massias, J. S., Smith, E. M. D., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2021). Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK. LUPUS, 30(4), 597-607. doi:10.1177/0961203320984251
Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood polyarteritis nodosa: An open label, randomised, Bayesian, non-inferiority trial.
Brogan, P. A., Arch, B., Hickey, H., Anton, J., Iglesias, E., Baildam, E., . . . Eleftheriou, D. (2021). Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood polyarteritis nodosa: An open label, randomised, Bayesian, non-inferiority trial.. Arthritis & rheumatology (Hoboken, N.J.). doi:10.1002/art.41730
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study
Smith, E. M. D., Rasul, S., Ciurtin, C., Al-Abadi, E., Armon, K., Bailey, K., . . . Hedrich, C. M. (2021). Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study. RHEUMATOLOGY, 60(11), 5271-5281. doi:10.1093/rheumatology/keab210
Behçet’s syndrome in children and young people in the United Kingdom & Republic of Ireland: a prospective epidemiological study
Taylor-Robinson, D. (2021). Behçet’s syndrome in children and young people in the United Kingdom &Republic of Ireland: a prospective epidemiological study. Rheumatology. doi:10.1093/rheumatology/keab084
Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study
Shoop-Worrall, S. J. W., Hyrich, K. L., Wedderburn, L. R., Thomson, W., Geifman, N., & CAPS the CLUSTER Consortium. (2021). Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study.. The Lancet. Rheumatology, 3(2), e111-e121. doi:10.1016/s2665-9913(20)30269-1
PULMONARY HYPERTENSION IN CHILDREN AND YOUNGPEOPLE WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Longthorpe, C., Harmer, M., Platt, C., Sit, J., Marks, S., Beresford, M., & Ramanan, A. (2021). PULMONARY HYPERTENSION IN CHILDREN AND YOUNGPEOPLE WITH SYSTEMIC LUPUS ERYTHEMATOSUS. In PEDIATRIC NEPHROLOGY Vol. 36 (pp. 3440). Retrieved from https://www.webofscience.com/
2020
A Panel of Urinary Proteins Predicts Active Lupus Nephritis and Response to Rituximab Treatment
Davies, J., Carlsson, E., Midgley, A., Smith, E., Bruce, I., Beresford, M., & Hedrich, C. (2020). A Panel of Urinary Proteins Predicts Active Lupus Nephritis and Response to Rituximab Treatment. ARTHRITIS & RHEUMATOLOGY, 72. Retrieved from http://gateway.webofknowledge.com/
Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019
Smith, E. M. D., Ainsworth, S., Beresford, M. W., Buys, V., Costello, W., Egert, Y., . . . Stones, S. R. (2020). Establishing an international awareness day for paediatric rheumatic diseases: reflections from the inaugural World Young Rheumatic Diseases (WORD) Day 2019. PEDIATRIC RHEUMATOLOGY, 18(1). doi:10.1186/s12969-020-00465-2
Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment
Davies, J. C., Midgley, A., Carlsson, E., Donohue, S., Bruce, I. N., Beresford, M. W., & Hedrich, C. M. (2020). Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment. RMD OPEN, 6(2). doi:10.1136/rmdopen-2020-001257
A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy
Wright, R. D., Bannerman, F., Beresford, M. W., & Oni, L. (2020). A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy. BMC Nephrology, 21. doi:10.1186/s12882-020-01888-5
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data.
Davies, R., De Cock, D., Kearsley-Fleet, L., Southwood, T., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2020). The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data. RHEUMATOLOGY, 59(6), 1391-1397. doi:10.1093/rheumatology/kez449
URINE AND SERUM S100 PROTEINS ASSOCIATE WITH LUPUS NEPHRITIS AND RESPONSE TO TREATMENT
Davies, J., Midgley, A., Donohue, S., Bruce, I. N., Beresford, M., & Hedrich, C. (2020). URINE AND SERUM S100 PROTEINS ASSOCIATE WITH LUPUS NEPHRITIS AND RESPONSE TO TREATMENT. In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 348). doi:10.1136/annrheumdis-2020-eular.1180
Clinical and Laboratory Characteristics in Juvenile-onset Systemic Lupus Erythematosus Across Age Groups
Massias, J., Smith, E., Beresford, M., & Hedrich, C. (2020). Clinical and Laboratory Characteristics in Juvenile-onset Systemic Lupus Erythematosus Across Age Groups. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 95-96). Retrieved from https://www.webofscience.com/
Differential Analysis of Serum and Urine S100 Proteins in Juvenile-onset Systemic Lupus Erythematosus (jSLE)
Donohue, S., Midgley, A., Davies, J., Wright, R., Bruce, I., Beresford, M., & Hedrich, C. (2020). Differential Analysis of Serum and Urine S100 Proteins in Juvenile-onset Systemic Lupus Erythematosus (jSLE). In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 96-97). Retrieved from https://www.webofscience.com/
Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE)
Donohue, S. J., Midgley, A., Davies, J. C., Wright, R. D., Bruce, I., Beresford, M. W., & Hedrich, C. M. (2020). Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE). CLINICAL IMMUNOLOGY, 214. doi:10.1016/j.clim.2020.108375
Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups
Massias, J. S., Smith, E. M. D., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., . . . Hedrich, C. M. (2020). Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. LUPUS, 29(5), 474-481. doi:10.1177/0961203320909156
European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative.
de Graeff, N., Groot, N., Brogan, P., Ozen, S., Avcin, T., Bader-Meunier, B., . . . Beresford, M. W. (2020). European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative (vol 58, pg 656, 2019). RHEUMATOLOGY, 59(4), 919. doi:10.1093/rheumatology/keaa057
Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study
Kearsley-Fleet, L., Heaf, E., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., . . . BCRD and BSPAR-ETN study groups. (2020). Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study. The Lancet Rheumatology, 2(4), e217-e226. doi:10.1016/s2665-9913(20)30025-4
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial
Ramanan, A. V., Dick, A. D., Guly, C., McKay, A., Jones, A. P., Hardwick, B., . . . APTITUDE Trial Management Group. (2020). Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. The Lancet Rheumatology, 2(3), e135-e141. doi:10.1016/s2665-9913(20)30008-4
Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts
Belot, A., Rice, G. I., Omarjee, S. O., Rouchon, Q., Smith, E. M. D., Moreews, M., . . . Wood, F. (2020). Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts. The Lancet Rheumatology, 2(2), e99-e109. doi:10.1016/s2665-9913(19)30142-0
Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.
Jones, A. P., Clayton, D., Nkhoma, G., Sherratt, F. C., Peak, M., Stones, S. R., . . . Baildam, E. M. (2020). Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.. Health Technology Assessment, 24(36), 1-152. doi:10.3310/hta24360
Neuropsychiatric Involvement in Juvenile-onset Systemic Lupus Erythematosus (JSLE): Data from the UK JSLE Cohort Study
Giani, T., Smith, E., Cimaz, R., Beresford, M., & Hedrich, C. (2020). Neuropsychiatric Involvement in Juvenile-onset Systemic Lupus Erythematosus (JSLE): Data from the UK JSLE Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 72. Retrieved from https://www.webofscience.com/
2019
Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options
Smith, E. M. D., Lythgoe, H., Midgley, A., Beresford, M. W., & Hedrich, C. M. (2019). Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. CLINICAL IMMUNOLOGY, 209. doi:10.1016/j.clim.2019.108274
cAMP Response Element Modulator α Induces Dual Specificity Protein Phosphatase 4 to Promote Effector T Cells in Juvenile-Onset Lupus
Hofmann, S. R., Mäbert, K., Kapplusch, F., Russ, S., Northey, S., Beresford, M. W., . . . Hedrich, C. M. (2019). cAMP Response Element Modulator α Induces Dual Specificity Protein Phosphatase 4 to Promote Effector T Cells in Juvenile-Onset Lupus. Journal of Immunology, 203(11), 2807-2816. doi:10.4049/jimmunol.1900760
Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus
Wright, R. D., Dimou, P., Northey, S. J., & Beresford, M. W. (2019). Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus. JOURNAL OF INFLAMMATION-LONDON, 16(1). doi:10.1186/s12950-019-0227-x
Biosimilar use in children and young people with juvenile idiopathic arthritis in a real-world setting in the United Kingdom
Kearsley-Fleet, L., Adam, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2019). Biosimilar use in children and young people with juvenile idiopathic arthritis in a real-world setting in the United Kingdom. In RHEUMATOLOGY Vol. 58. Retrieved from https://www.webofscience.com/
The European network for care of children with paediatric rheumatic diseases: care across borders
Dolezalova, P., Anton, J., Avcin, T., Beresford, M. W., Brogan, P. A., Constantin, T., . . . Silvestri, G. (2019). The European network for care of children with paediatric rheumatic diseases: care across borders. RHEUMATOLOGY, 58(7), 1188-1195. doi:10.1093/rheumatology/key439
The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial
Rooney, M., Bishop, N., Davidson, J., Beresford, M. W., Pilkington, C., McDonagh, J., . . . Verghis, R. (2019). The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial. ECLINICALMEDICINE, 12, 79-87. doi:10.1016/j.eclinm.2019.06.004
Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.
Horton, S., Jones, A. P., Guly, C. M., Hardwick, B., Beresford, M. W., Lee, R. W. J., . . . Ramanan, A. V. (2019). Adalimumab in juvenile-idiopathic arthritis-associated uveitis (JIA-U): 5-year follow-up of the Bristol participants of the SYCAMORE trial.. American journal of ophthalmology. doi:10.1016/j.ajo.2019.06.007
The human glomerular endothelial cells are potent pro-inflammatory contributors in an <i>in vitro</i> model of lupus nephritis
Dimou, P., Wright, R. D., Budge, K. L., Midgley, A., Satchell, S. C., Peak, M., & Beresford, M. W. (2019). The human glomerular endothelial cells are potent pro-inflammatory contributors in an <i>in vitro</i> model of lupus nephritis. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-44868-y
A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK
Baildam, E., Jones, A., Clayton, D., Nkoma, G., Peak, M., Ramanan, A., . . . Beresford, M. (2019). A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1934). doi:10.1136/annrheumdis-2019-eular.6751
DIAGNOSIS AND INITIAL MANAGEMENT OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UK AND IRELAND
Lythgoe, H., Pain, C., Smith, E., & Beresford, M. (2019). DIAGNOSIS AND INITIAL MANAGEMENT OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS IN THE UK AND IRELAND. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1329). doi:10.1136/annrheumdis-2019-eular.1587
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO
Ramanan, A. V., Hampson, L. V., Lythgoe, H., Jones, A. P., Hardwick, B., Hind, H., . . . Beresford, M. W. (2019). Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. PLOS ONE, 14(6). doi:10.1371/journal.pone.0215739
HOT: MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS 2019 AND BEYOND
Beresford, M. (2019). HOT: MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS 2019 AND BEYOND. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 42). doi:10.1136/annrheumdis-2019-eular.8429
IDENTIFYING THE PRIMARY OUTCOME MEASURE AND PROTOCOL COMPONENTS FOR A PROSPECTIVE FEASIBILITY STUDY OF CORTICOSTEROID REGIMENS FOR CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS USING CONSENSUS METHODS WITH YOUNG PEOPLE, FAMILIES AND PROFESSIONALS
Stones, S., Bagley, H., Jones, A., Mcerlane, F., Moitt, T., Nkhoma, G., . . . Baildam, E. (2019). IDENTIFYING THE PRIMARY OUTCOME MEASURE AND PROTOCOL COMPONENTS FOR A PROSPECTIVE FEASIBILITY STUDY OF CORTICOSTEROID REGIMENS FOR CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS USING CONSENSUS METHODS WITH YOUNG PEOPLE, FAMILIES AND PROFESSIONALS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 1934-1935). doi:10.1136/annrheumdis-2019-eular.1799
WHAT TO CHOOSE: A SECOND TNFI OR AN ALTERNATIVE CLASS OF BIOLOGIC FOR PATIENTS WITH JIA WHO HAVE FAILED THEIR FIRST TNFI
Kearsley-Fleet, L., Davies, R., Page, J., Baildam, E., Beresford, M., Foster, H., . . . Hyrich, K. (2019). WHAT TO CHOOSE: A SECOND TNFI OR AN ALTERNATIVE CLASS OF BIOLOGIC FOR PATIENTS WITH JIA WHO HAVE FAILED THEIR FIRST TNFI. In ANNALS OF THE RHEUMATIC DISEASES Vol. 78 (pp. 74-75). doi:10.1136/annrheumdis-2019-eular.415
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus
Brunner, H. I., Holland, M. J., Beresford, M. W., Ardoin, S. P., Appenzeller, S., Silva, C. A., . . . Maldonado, I. (2019). American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 71(5), 579-590. doi:10.1002/acr.23834
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
Ramanan, A. V., Dick, A. D., Jones, A. P., Hughes, D. A., McKay, A., Rosala-Halas, A., . . . Grp, S. Y. C. A. M. O. R. E. S. (2019). Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. HEALTH TECHNOLOGY ASSESSMENT, 23(15), 1-139. doi:10.3310/hta23150
Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients
Abdelrahman, N., Beresford, M. W., & Leone, V. (2019). Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients. LUPUS, 28(5), 667-674. doi:10.1177/0961203319840699
European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative
de Graeff, N., Groot, N., Ozen, S., Eleftheriou, D., Avcin, T., Bader-Meunier, B., . . . Beresford, M. W. (2019). European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative. RHEUMATOLOGY, 58(4), 672-682. doi:10.1093/rheumatology/key344
European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative
De Graeff, N., Groot, N., Brogan, P., Ozen, S., Avcin, T., Bader-Meunier, B., . . . Beresford, M. (2019). European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – the SHARE initiative. Rheumatology, 58(4), 656-671. doi:10.1093/rheumatology/key322
HIGH SEQUENTIAL USE OF TUMOUR NECROSIS FACTOR INHIBITORS IN A COHORT OF CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED KINGDOM
Kearsley-Fleet, L., Heaf, E. D., Davies, R., De Cock, D., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2019). HIGH SEQUENTIAL USE OF TUMOUR NECROSIS FACTOR INHIBITORS IN A COHORT OF CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 58 (pp. 32). Retrieved from https://www.webofscience.com/
Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio
Dawson, S. R., Linton, E., Beicher, K., Gale, R., Patel, P., Ghanchi, F., . . . Barry, R. (2019). Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio. EYE, 33(4), 610-618. doi:10.1038/s41433-018-0251-8
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
Ozen, S., Marks, S. D., Brogan, P., Groot, N., de Graeff, N., Avcin, T., . . . Beresford, M. W. (2019). European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.. Rheumatology, 58(9), 1607-1616. doi:10.1093/rheumatology/kez041
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Smith, E., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., Davidson, J., . . . Hedrich, C. M. (2019). Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.. Lupus, 961203319836712. doi:10.1177/0961203319836712
Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis
Kearsley-Fleet, L., Gonzalez, L. V., Steinke, D., Davies, R., De Cock, D., Baildam, E., . . . Hyrich, K. L. (2019). Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis. RHEUMATOLOGY, 58(8), 1453-1458. doi:10.1093/rheumatology/kez048
Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis
Hughes, D. A., Culeddu, G., Plumpton, C. O., Wood, E., Dick, A. D., Jones, A. P., . . . Ramanan, A. V. (2019). Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Ophthalmology, 126(3), 415-424. doi:10.1016/j.ophtha.2018.09.043
Reply.
Hughes, D. A., Culeddu, G., Plumpton, C., Wood, E., Dick, A. D., Beresford, M. W., & Ramanan, A. V. (2019). Reply.. Ophthalmology, 126(3), e24-e25. doi:10.1016/j.ophtha.2018.12.005
Working together to deliver stratified medicine research effectively
Attar, S. G., Poustie, V. J., Hawcutt, D. B., Oni, L., Beresford, M. W., & Pirmohamed, M. (2019). Working together to deliver stratified medicine research effectively. British Medical Bulletin. doi:10.1093/bmb/ldz003
Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
Martini, A., Ravelli, A., Avcin, T., Beresford, M. W., Burgos-Vargas, R., Cuttica, R., . . . Ruperto, N. (2019). Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. JOURNAL OF RHEUMATOLOGY, 46(2), 190-197. doi:10.3899/jrheum.180168
Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom
Kearsley-Fleet, L., Sampath, S., McCann, L. J., Baildam, E., Beresford, M. W., Davies, R., . . . Hyrich, K. L. (2019). Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom. RHEUMATOLOGY, 58(2), 331-335. doi:10.1093/rheumatology/key306
A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity
Smith, E. M. D., Eleuteri, A., Goilav, B., Lewandowski, L., Phuti, A., Rubinstein, T., . . . Beresford, M. W. (2019). A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. CLINICAL IMMUNOLOGY, 198, 71-78. doi:10.1016/j.clim.2018.10.021
A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK
Jones, A., Clayton, D., Nkhoma, G., Sherratt, F., Peak, M., Ramanan, A., . . . Baildam, E. (2019). A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK. In RHEUMATOLOGY Vol. 58 (pp. 7). Retrieved from https://www.webofscience.com/
Big data and stratified medicine: what does it mean for children?
Ding, W. Y., Beresford, M. W., Saleem, M. A., & Ramanan, A. V. (2019). Big data and stratified medicine: what does it mean for children?. ARCHIVES OF DISEASE IN CHILDHOOD, 104(4), 389-394. doi:10.1136/archdischild-2018-315125
Chronic Nonbacterial Osteomyelitis
McCann, L., Beresford, M. W., Hahn, G., & Hedrich, C. M. (2019). Chronic Nonbacterial Osteomyelitis. In Auto-Inflammatory Syndromes (pp. 227-248). Springer International Publishing. doi:10.1007/978-3-319-96929-9_17
Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals
Stones, S. R., Bagley, H., Beresford, M. W., Jones, A., McErlane, F., Moitt, T., . . . Baildam, E. M. (2019). Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals. In RHEUMATOLOGY Vol. 58. Retrieved from https://www.webofscience.com/
Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis REPLY
Hughes, D. A., Culeddu, G., Plumpton, C., Wood, E., Dick, A. D., Beresford, M. W., & Ramanan, A. V. (2019). Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis REPLY. OPHTHALMOLOGY, 126(3), E24-E25. doi:10.1016/j.ophtha.2018.12.005
S100A8/A9 and S100A12 may be biomarkers for juvenile-onset systemic lupus erythematosus
Donohue, S. J., Midgley, A., Bruce, I., Beresford, M. W., & Hedrich, C. M. (2019). S100A8/A9 and S100A12 may be biomarkers for juvenile-onset systemic lupus erythematosus. In RHEUMATOLOGY Vol. 58. Retrieved from https://www.webofscience.com/
Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
Kearsley-Fleet, L., Beresford, M. W., Davies, R., De Cock, D., Baildam, E., Foster, H. E., . . . Hyrich, K. L. (2019). Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra. RHEUMATOLOGY, 58(1), 94-102. doi:10.1093/rheumatology/key262
2018
Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials
Sherratt, F. C., Roper, L., Stones, S. R., McErlane, F., Peak, M., Beresford, M. W., . . . Young, B. (2018). Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials. PEDIATRIC RHEUMATOLOGY, 16. doi:10.1186/s12969-018-0293-2
Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort
Smith, E. M. D., Lewandowski, L. B., Jorgensen, A. L., Phuti, A., Nourse, P., Scott, C., & Beresford, M. W. (2018). Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort. LUPUS, 27(14), 2190-2199. doi:10.1177/0961203318808376
Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis
Wright, R. D., & Beresford, M. W. (2018). Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 315(6), F1683-F1694. doi:10.1152/ajprenal.00512.2017
Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study
Smith, E. M. D., Yin, P., Jorgensen, A. L., & Beresford, M. W. (2018). Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study. LUPUS, 27(13), 2020-2028. doi:10.1177/0961203318801526
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus
Holland, M. J., Beresford, M. W., Feldman, B. M., Huggins, J., Norambuena, X., Silva, C. A., . . . Brunner, H. I. (2018). Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 70(11), 1621-1629. doi:10.1002/acr.23531
The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review
Peterknecht, E., Keasey, M. P., & Beresford, M. W. (2018). The effectiveness and safety of biological therapeutics in juvenile-onset systemic lupus erythematosus (JSLE): a systematic review. LUPUS, 27(13), 2135-2145. doi:10.1177/0961203318804879
The transition of adolescents with juvenile idiopathic arthritis or epilepsy from paediatric health-care services to adult health-care services: A scoping review of the literature and a synthesis of the evidence
Burke, L., Kirkham, J., Arnott, J., Gray, V., Peak, M., & WBeresford, M. (2018). The transition of adolescents with juvenile idiopathic arthritis or epilepsy from paediatric health-care services to adult health-care services: A scoping review of the literature and a synthesis of the evidence. JOURNAL OF CHILD HEALTH CARE, 22(3), 332-358. doi:10.1177/1367493517753330
American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus
Brunner, H. I., Holland, M., Beresford, M. W., Ardoin, S. P., Appenzeller, S., Silva, C. A., . . . Ying, J. (2018). American College of Rheumatology Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 70(6), 813-822. doi:10.1002/acr.23557
BIOSIMILAR USE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM
De Cock, D., Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M., Foster, H., . . . Hyrich, K. (2018). BIOSIMILAR USE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 485). doi:10.1136/annrheumdis-2018-eular.4477
METHOTREXATE DRUG SURVIVAL AND ADVERSE EFFECTS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
Kearsley-Fleet, L., Gonzalez, L. V., Steinke, D., Davies, R., De Cock, D., Baildam, E., . . . Hyrich, K. L. (2018). METHOTREXATE DRUG SURVIVAL AND ADVERSE EFFECTS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 493). doi:10.1136/annrheumdis-2018-eular.1276
Treating juvenile idiopathic arthritis to target: recommendations of an international task force
Ravelli, A., Consolaro, A., Horneff, G., Laxer, R. M., Lovell, D. J., Wulffraat, N. M., . . . Smolen, J. S. (2018). Treating juvenile idiopathic arthritis to target: recommendations of an international task force. ANNALS OF THE RHEUMATIC DISEASES, 77(6), 819-828. doi:10.1136/annrheumdis-2018-213030
Anti-neutrophil cytoplasmic antibodies and their clinical significance
Suwanchote, S., Rachayon, M., Rodsaward, P., Wongpiyabovorn, J., Deekajorndech, T., Wright, H. L., . . . Chiewchengchol, D. (2018). Anti-neutrophil cytoplasmic antibodies and their clinical significance. CLINICAL RHEUMATOLOGY, 37(4), 875-884. doi:10.1007/s10067-018-4062-x
Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options
Hedrich, C. M., Smith, E. M. D., & Beresford, M. W. (2018). Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options. Best Practice and Research: Clinical Rheumatology. doi:10.1016/j.berh.2018.02.001
Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes
Ramanathan, K., Glaser, A., Lythgoe, H., Ong, J., Beresford, M. W., Midgley, A., & Wright, H. L. (2018). Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes. RHEUMATOLOGY, 57(3), 488-498. doi:10.1093/rheumatology/kex441
Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative
Kuemmerle-Deschner, J. B., Hansmann, S., Wulffraat, N. M., Vastert, S. J., Hens, K., Anton, J., . . . Benseler, S. M. (2018). Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative. ANNALS OF THE RHEUMATIC DISEASES, 77(3), 319-327. doi:10.1136/annrheumdis-2017-211904
Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study
Smith, E. M. D., Yin, P., Jorgensen, A., & Beresford, M. (2018). Clinical predictors of proteinuric remission following an LN flare - evidence from the UK JSLE cohort study. Pediatric Rheumatology Online Journal, 16(1). doi:10.1186/s12969-018-0230-4
Child-centred research is the key to progress
Beresford, M. W., & Ramanan, A. V. (2018). Child-centred research is the key to progress. NATURE REVIEWS RHEUMATOLOGY, 14(2), 69-70. doi:10.1038/nrrheum.2017.214
Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma.
Lythgoe, H., Baildam, E., Beresford, M. W., Cleary, G., McCann, L. J., & Pain, C. E. (2018). Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma. RHEUMATOLOGY, 57(2), 398-401. doi:10.1093/rheumatology/kex382
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
Ramanan, A. V., Dick, A. D., Jones, A. P., Guly, C., Hardwick, B., Hickey, H., . . . Beresford, M. W. (2018). A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial). BMC RHEUMATOLOGY, 2(1). doi:10.1186/s41927-018-0010-2
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.
McCann, L. J., Pilkington, C. A., Huber, A. M., Ravelli, A., Appelbe, D., Kirkham, J. J., . . . Beresford, M. W. (2018). Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.. Annals of the rheumatic diseases, 77(2), 241-250. doi:10.1136/annrheumdis-2017-212141
Assessing the sensitivity of ISG and PEDBD criteria in a UK cohort of children and young people with Behcet's disease
Pain, C. E., Latham, E., Beresford, M. W., Fortune, F., Moots, R. J., Murphy, R., . . . Brogan, P. (2018). Assessing the sensitivity of ISG and PEDBD criteria in a UK cohort of children and young people with Behcet's disease. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 36 (pp. S186). Retrieved from https://www.webofscience.com/
BIOLOGIC REFRACTORY DISEASE IN A COHORT STUDY OF CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED KINGDOM
Heaf, E., Kearsley-Fleet, L., Davies, R., De Cock, D., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2018). BIOLOGIC REFRACTORY DISEASE IN A COHORT STUDY OF CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 57 (pp. 25). Retrieved from https://www.webofscience.com/
BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM
Decock, D., Davies, R., Kearsley-Fleet, L., Baildam, E., Beresford, M., Foster, H., . . . Hyrich, K. (2018). BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 57. Retrieved from https://www.webofscience.com/
BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN AREAL-WORLD SETTING IN THE UNITED KINGDOM
De Cock, D., Kearsley-Fleet, L., Baidam, E., Beresford, M., Foster, H., Southwood, T., . . . Hyrich, K. (2018). BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN AREAL-WORLD SETTING IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 57. Retrieved from https://www.webofscience.com/
Biologic Refractory Disease in a Cohort Study of Children and Young People with Juvenile Idiopathic Arthritis from the United Kingdom
Heaf, E., Kearsley-Fleet, L., Davies, R., De Cock, D., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2018). Biologic Refractory Disease in a Cohort Study of Children and Young People with Juvenile Idiopathic Arthritis from the United Kingdom. In ARTHRITIS & RHEUMATOLOGY Vol. 70. Retrieved from https://www.webofscience.com/
SLE: SCIENCE IN PAEDIATRIC AND ADOLESCENT PATIENTS
Beresford, M. (2018). SLE: SCIENCE IN PAEDIATRIC AND ADOLESCENT PATIENTS. In RHEUMATOLOGY Vol. 57. Retrieved from https://www.webofscience.com/
2017
European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative
Groot, N., de Graeff, N., Marks, S. D., Brogan, P., Avcin, T., Bader-Meunier, B., . . . Kamphuis, S. (2017). European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. ANNALS OF THE RHEUMATIC DISEASES, 76(12), 1965-1973. doi:10.1136/annrheumdis-2017-211898
USING A PRE-CLINIC SCREENING TOOL TO SUPPORT YOUNG PEOPLE WITH LUPUS IN PRIORITISING ISSUES FOR DISCUSSION IN CLINIC APPOINTMENTS
Wilson, E., Etheridge, J., Smith, E., & Beresford, M. W. (2017). USING A PRE-CLINIC SCREENING TOOL TO SUPPORT YOUNG PEOPLE WITH LUPUS IN PRIORITISING ISSUES FOR DISCUSSION IN CLINIC APPOINTMENTS. In RHEUMATOLOGY Vol. 56 (pp. 19-20). Retrieved from https://www.webofscience.com/
Urinary biomarkers in childhood lupus nephritis
Smith, E. M. D., & Beresford, M. W. (2017). Urinary biomarkers in childhood lupus nephritis. CLINICAL IMMUNOLOGY, 185, 21-31. doi:10.1016/j.clim.2016.06.010
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects
Rider, L. G., Ruperto, N., Pistorio, A., Erman, B., Bayat, N., Lachenbruch, P. A., . . . Aggarwal, R. (2017). 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. RHEUMATOLOGY, 56(11), 1884-1893. doi:10.1093/rheumatology/kex226
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort
Tansley, S. L., Simou, S., Shaddick, G., Betteridge, Z. E., Almeida, B., Gunawardena, H., . . . McHugh, N. J. (2017). Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort. JOURNAL OF AUTOIMMUNITY, 84, 55-64. doi:10.1016/j.jaut.2017.06.007
European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative
Groot, N., de Graeff, N., Avcin, T., Bader-Meunier, B., Brogan, P., Dolezalova, P., . . . Beresford, M. W. (2017). European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. ANNALS OF THE RHEUMATIC DISEASES, 76(11), 1788-1796. doi:10.1136/annrheumdis-2016-210960
Developing an Education Resource for the paediatric BILAG index
Richards, E., Poutney, M., Holt, A., Prescott, D., Smith, E., Roberts, C., & Beresford, M. (2017). Developing an Education Resource for the paediatric BILAG index. In RHEUMATOLOGY Vol. 56. doi:10.1093/rheumatology/kex356.019
Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
Smith, E. M. D., Jorgensen, A. L., & Beresford, M. W. (2017). Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.. Lupus, 26(11), 1212-1217. doi:10.1177/0961203317702253
Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis
Lythgoe, H., Morgan, T., Heaf, E., Lloyd, O., Al-Abadi, E., Armon, K., . . . Beresford, M. W. (2017). Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis. LUPUS, 26(12), 1285-1290. doi:10.1177/0961203317700484
Inter-observer variability of the histological classification of lupus glomerulonephritis in children
Oni, L., Beresford, M. W., Witte, D., Chatzitolios, A., Sebire, N., Abulaban, K., . . . Brunner, H. I. (2017). Inter-observer variability of the histological classification of lupus glomerulonephritis in children. LUPUS, 26(11), 1205-1211. doi:10.1177/0961203317706558
Validation of Flare Criteria for Children and Adolescents with Systemic Lupus Erythematosus
Brunner, H. I., Holland, M. J., Beresford, M. W., Ruperto, N., Ardoin, S. P., Appenzeller, S., . . . Ying, J. (2017). Validation of Flare Criteria for Children and Adolescents with Systemic Lupus Erythematosus. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from https://www.webofscience.com/
Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.
Ramanan, A. V., Dick, A. D., & Beresford, M. W. (2017). Adalimumab for Uveitis in Juvenile Idiopathic Arthritis.. The New England journal of medicine, 377(8), 789-790. doi:10.1056/nejmc1708646
Preface: Recent advances in autoimmune and auto-inflammatory diseases in childhood
Ramanan, A. V., & Beresford, M. W. (2017). Preface: Recent advances in autoimmune and auto-inflammatory diseases in childhood. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 31(4), 439-440. doi:10.1016/j.berh.2018.03.001
Optimising the use of medicines to reduce acute kidney injury in children and babies
Oni, L., Hawcutt, D. B., Turner, M. A., Beresford, M. W., McWilliam, S., Barton, C., . . . Antoine, D. J. (2017). Optimising the use of medicines to reduce acute kidney injury in children and babies. Pharmacology and Therapeutics, 174, 55-62. doi:10.1016/j.pharmthera.2017.02.018
SHARE RECOMMENDATIONS ON SYSTEMIC VASCULITIDES
Beresford, M. W. (2017). SHARE RECOMMENDATIONS ON SYSTEMIC VASCULITIDES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 76 (pp. 9). doi:10.1136/annrheumdis-2017-eular.7205
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Grp, S. Y. C. A. M. O. R. E. S. (2017). Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis. New England Journal of Medicine, 376(17), 1637-1646. doi:10.1056/NEJMoa1614160
PRESCRIBING PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS: A SURVEY OF CURRENT PRACTICE IN THE UNITED KINGDOM
Hawley, D. P., Foster, H. E., Beresford, M. W., Ramanan, A., Rapley, T., & McErlane, F. (2017). PRESCRIBING PATTERNS IN JUVENILE IDIOPATHIC ARTHRITIS: A SURVEY OF CURRENT PRACTICE IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56 (pp. 168-169). Retrieved from https://www.webofscience.com/
International validation of a urinary biomarker panel for identification of active lupus nephritis in children.
Smith, E. M. D., Jorgensen, A. L., Midgley, A., Oni, L., Goilav, B., Putterman, C., . . . Beresford, M. W. (2017). International validation of a urinary biomarker panel for identification of active lupus nephritis in children.. Pediatric Nephrology, 32(2), 283-295. doi:10.1007/s00467-016-3485-3
Mortality rates are increased in patients with systemic juvenile idiopathic arthritis.
Davies, R., Southwood, T., Kearsley-Fleet, L., Lunt, M., Baildam, E., Beresford, M. W., . . . Hyrich, K. L. (2017). Mortality rates are increased in patients with systemic juvenile idiopathic arthritis. ARCHIVES OF DISEASE IN CHILDHOOD, 102(2). doi:10.1136/archdischild-2016-311571
BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM
De Cock, D., Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2017). BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56 (pp. 16). Retrieved from https://www.webofscience.com/
BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM
Rice, H., Beresford, M. W., Brogan, P., Fortune, F., Moots, R. J., Murphy, R., & Pain, C. E. (2017). BRITISH PAEDIATRIC SURVEILLANCE UNIT (BPSU) STUDY OF BEHCET'S SYNDROME IN CHILDREN AND YOUNG PEOPLE IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
Biosimilar Use in Children and Young People with Juvenile Idiopathic Arthritis in a Real-World Setting in the United Kingdom
De Cock, D., Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2017). Biosimilar Use in Children and Young People with Juvenile Idiopathic Arthritis in a Real-World Setting in the United Kingdom. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from https://www.webofscience.com/
CLINICAL FACTORS ASSOCIATED WITH NON-RESPONSE TO METHOTREXATE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS RESPONSE TO TREATMENT CONSORTIUM
Sampath, S., Sergeant, J. C., Viatte, S., Carrasco, R., Cobb, J., Smith, S. L., . . . Thomson, W. (2017). CLINICAL FACTORS ASSOCIATED WITH NON-RESPONSE TO METHOTREXATE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS RESPONSE TO TREATMENT CONSORTIUM. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
DEVELOPING A UK/ROI STUDY OF THE INCIDENCE OF JSLE IN CHILDREN AND YOUNG PEOPLE AND THEIR ACCESS TO CARE: A COLLABORATIVE APPROACH
Lythgoe, H., Smith, E., Pain, C., Murphy, R., Killeen, O., Pilkington, C., & Beresford, M. W. (2017). DEVELOPING A UK/ROI STUDY OF THE INCIDENCE OF JSLE IN CHILDREN AND YOUNG PEOPLE AND THEIR ACCESS TO CARE: A COLLABORATIVE APPROACH. In RHEUMATOLOGY Vol. 56 (pp. 3-+). Retrieved from https://www.webofscience.com/
DISEASE ACTIVITY STATUS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
Abdelrahman, N., Beresford, M. W., & Leone, V. (2017). DISEASE ACTIVITY STATUS IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 56 (pp. 16-+). Retrieved from https://www.webofscience.com/
GENOME-WIDE ASSOCIATION STUDY OF METHOTREXATE NON-RESPONSE IN JUVENILE IDIOPATHIC ARTHRITIS
Sampath, S., Viatte, S., Smith, S. L., Cobb, J., Hinks, A., Hyrich, K. L., . . . Thomson, W. (2017). GENOME-WIDE ASSOCIATION STUDY OF METHOTREXATE NON-RESPONSE IN JUVENILE IDIOPATHIC ARTHRITIS. In RHEUMATOLOGY Vol. 56 (pp. 14-15). Retrieved from https://www.webofscience.com/
JUVENILE-ONSET LUPUS NEPHRITIS: CHARACTERISING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN URINARY BIOMARKER PRODUCTION
Dimou, P., Peak, M., Midgley, A., Satchell, S. C., Wright, R. D., & Beresford, M. W. (2017). JUVENILE-ONSET LUPUS NEPHRITIS: CHARACTERISING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN URINARY BIOMARKER PRODUCTION. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
LUPUS AND YOU: DEVELOPING A WORKSHOP FOR YOUNG PEOPLE WITH LUPUS AND THEIR FAMILIES
Wilson, E., Lythgoe, H., Smith, E., Preston, J., & Beresford, M. W. (2017). LUPUS AND YOU: DEVELOPING A WORKSHOP FOR YOUNG PEOPLE WITH LUPUS AND THEIR FAMILIES. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
SHORT-TERM OUTCOMES IN PATIENTS WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH EITHER TOCILIZUMAB OR ANAKINRA IN A REAL-WORLD SETTING IN THE UNITED KINGDOM
Kearsley-Fleet, L., De Cock, D., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2017). SHORT-TERM OUTCOMES IN PATIENTS WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH EITHER TOCILIZUMAB OR ANAKINRA IN A REAL-WORLD SETTING IN THE UNITED KINGDOM. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
Short-Term Outcomes in Patients with Systemic-Onset Juvenile Idiopathic Arthritis Treated with Either Tocilizumab or Anakinra in a Real-World Setting in the United Kingdom
Kearsley-Fleet, L., De Cock, D., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2017). Short-Term Outcomes in Patients with Systemic-Onset Juvenile Idiopathic Arthritis Treated with Either Tocilizumab or Anakinra in a Real-World Setting in the United Kingdom. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from https://www.webofscience.com/
THE INFLUENCE OF RITUXIMAB ON THE METABOLOME OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS
Glaser, A., Wright, H. L., Midgley, A., Phelan, M. M., Peak, M., & Beresford, M. W. (2017). THE INFLUENCE OF RITUXIMAB ON THE METABOLOME OF JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS. In RHEUMATOLOGY Vol. 56. Retrieved from https://www.webofscience.com/
Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus
An, J., Briggs, T. A., Dumax-Vorzet, A., Alarcon-Riquelme, M. E., Belot, A., Beresford, M., . . . Elkon, K. B. (2017). Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus. ARTHRITIS & RHEUMATOLOGY, 69(1), 131-142. doi:10.1002/art.39810
Tools for the Individualized Therapy of Teicoplanin for Neonates and Children
Ramos-Martin, V., Neely, M. N., Padmore, K., Peak, M., Beresford, M. W., Turner, M. A., . . . Hope, W. W. (2017). Tools for the Individualized Therapy of Teicoplanin for Neonates and Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61(10). doi:10.1128/AAC.00707-17
UNUSUAL PRESENTATIONS OF PAEDIATRIC SARCOID
Macfarlane, K., Cleary, G., Baildam, E., McCann, L., Beresford, M. W., & Pain, C. E. (2017). UNUSUAL PRESENTATIONS OF PAEDIATRIC SARCOID. In RHEUMATOLOGY Vol. 56 (pp. 17-18). Retrieved from https://www.webofscience.com/
Validation of Clinically Relevant Improvement in Children and Adolescents with cSLE
Aydin, P. O. A., Holland, M. J., Appenzeller, S., Ardoin, S. P., Avcin, T., Beresford, M. W., . . . Brunner, H. I. (2017). Validation of Clinically Relevant Improvement in Children and Adolescents with cSLE. In ARTHRITIS & RHEUMATOLOGY Vol. 69. Retrieved from https://www.webofscience.com/
2016
Differences in disease phenotype and severity in SLE across age groups
Ambrose, N., Morgan, T. A., Galloway, J., Ionnoau, Y., Beresford, M. W., & Isenberg, D. A. (2016). Differences in disease phenotype and severity in SLE across age groups. LUPUS, 25(14), 1542-1550. doi:10.1177/0961203316644333
Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.
Ramos-Martín, V., Neely, M. N., McGowan, P., Siner, S., Padmore, K., Peak, M., . . . Hope, W. W. (2016). Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy.. The Journal of antimicrobial chemotherapy, 71(11), 3168-3178. doi:10.1093/jac/dkw295
Clinical Factors Associated with Non-Response to Methotrexate in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Response to Treatment Consortium
Sampath, S., Sergeant, J. C., Viatte, S., Carrasco, R., Cobb, J., Smith, S., . . . Thomson, W. (2016). Clinical Factors Associated with Non-Response to Methotrexate in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Response to Treatment Consortium. In ARTHRITIS & RHEUMATOLOGY Vol. 68. Retrieved from https://www.webofscience.com/
FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS
Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2015). FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS. RHEUMATOLOGY, 54, 156. Retrieved from https://www.webofscience.com/
Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers
Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2016). Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers. RHEUMATOLOGY, 55(9), 1556-1565. doi:10.1093/rheumatology/kev429
Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis
Patel, M., Oni, L., Midgley, A., Smith, E., Tullus, K., Marks, S. D., . . . Beresford, M. W. (2016). Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. LUPUS, 25(9), 1040-1044. doi:10.1177/0961203316631634
ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL
Ramanan, A. V., Dick, A. D., Jones, A. P., McKay, A., Williamson, P. R., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2016). ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 264-265). doi:10.1136/annrheumdis-2016-eular.6053
EFFECT OF TYPE 1 AND 2 INTERFERONS ON NEUTROPHIL APOPTOSIS IN NAIVE AND TNF ALPHA PRIMED NEUTROPHILS
Irwin, S., Midgley, A., Wright, R., Peak, M., & Beresford, M. (2016). EFFECT OF TYPE 1 AND 2 INTERFERONS ON NEUTROPHIL APOPTOSIS IN NAIVE AND TNF ALPHA PRIMED NEUTROPHILS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 428). doi:10.1136/annrheumdis-2016-eular.4236
EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS
Lythgoe, H., Morgan, T., Heaf, E., Lloyd, O., & Beresford, M. W. (2016). EVALUATION OF THE ACR AND SLICC CLASSIFICATION CRITERIA IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS: A LONGITUDINAL ANALYSIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 139). doi:10.1136/annrheumdis-2016-eular.3430
INVESTIGATING THE NEUTROPHIL-MACROPHAGE INTERPLAY IN JUVENILE LUPUS NEPHRITIS PATHOGENESIS
Dimou, P., Midgley, A., Peak, M., Wright, R. D., & Beresford, M. W. (2016). INVESTIGATING THE NEUTROPHIL-MACROPHAGE INTERPLAY IN JUVENILE LUPUS NEPHRITIS PATHOGENESIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 914-915). doi:10.1136/annrheumdis-2016-eular.5116
INVESTIGATING THE PHAGOCYTIC POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS
Glaser, A. E. A., Wright, H. L., Midgley, A., Peak, M., & Beresford, M. W. (2016). INVESTIGATING THE PHAGOCYTIC POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 941). doi:10.1136/annrheumdis-2016-eular.5342
Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus
Thorbinson, C., Oni, L., Smith, E., Midgley, A., & Beresford, M. W. (2016). Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus. PEDIATRIC DRUGS, 18(3), 181-195. doi:10.1007/s40272-016-0170-8
SHARE RECOMMENDATIONS ON CONNECTIVE TISSUE DISEASES
Beresford, M. W. (2016). SHARE RECOMMENDATIONS ON CONNECTIVE TISSUE DISEASES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 75 (pp. 16). doi:10.1136/annrheumdis-2016-eular.6387
Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity
Midgley, A., & Beresford, M. W. (2016). Increased expression of low density granulocytes in juvenile-onset systemic lupus erythematosus patients correlates with disease activity. LUPUS, 25(4), 407-411. doi:10.1177/0961203315608959
Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling
Chiewchengchol, D., Wright, H. L., Thomas, H. B., Lam, C. W., Roberts, K. J., Hirankarn, N., . . . Edwards, S. W. (2016). Differential changes in gene expression in human neutrophils following TNF-α stimulation: Up-regulation of anti-apoptotic proteins and down-regulation of proteins involved in death receptor signaling. IMMUNITY INFLAMMATION AND DISEASE, 4(1), 35-44. doi:10.1002/iid3.90
A DENSE FINE SPECKLE PATTERN ON IMMUNOFLUORESCENCE IS STRONGLY ASSOCIATED WITH THE DEVELOPMENT OF UVEITIS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS
Tansley, S. L., Tansley, S. L., Dunphy, J., Jobling, A. A. C., Carrasco, R., Midgley, A., . . . McHugh, N. J. (2016). A DENSE FINE SPECKLE PATTERN ON IMMUNOFLUORESCENCE IS STRONGLY ASSOCIATED WITH THE DEVELOPMENT OF UVEITIS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS. In RHEUMATOLOGY Vol. 55 (pp. 57-58). Retrieved from https://www.webofscience.com/
ACTIVATION OF THE STAT1 PATHWAY BY TYPE 1 AND 2 INTERFERONS AND SUBSEQUENT EFFECT ON NEUTROPHIL APOPTOSIS
Irwin, S., Midgley, A., Wright, R. D., Peak, M., & Beresford, M. W. (2016). ACTIVATION OF THE STAT1 PATHWAY BY TYPE 1 AND 2 INTERFERONS AND SUBSEQUENT EFFECT ON NEUTROPHIL APOPTOSIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S58). Retrieved from https://www.webofscience.com/
Frequency of the Systemic Lupus Collaborating Clinics- Damage Index Items in Three Registries of Childhood-Onset Systemic Lupus Erythematosus
Holland, M. J., Beresford, M. W., Ruperto, N., Watts, A., Wiley, K., Cortis, E., . . . Brunner, H. I. (2016). Frequency of the Systemic Lupus Collaborating Clinics- Damage Index Items in Three Registries of Childhood-Onset Systemic Lupus Erythematosus. In ARTHRITIS & RHEUMATOLOGY Vol. 68. Retrieved from https://www.webofscience.com/
JUVENILE-ONSET LUPUS NEPHRITIS: INVESTIGATING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN NOVEL URINE BIOMARKER PRODUCTION
Dimou, P., Midgley, A., Peak, M., Satchell, S. C., Wright, R. D., & Beresford, M. W. (2016). JUVENILE-ONSET LUPUS NEPHRITIS: INVESTIGATING THE ROLE OF THE GLOMERULAR ENDOTHELIAL CELLS IN NOVEL URINE BIOMARKER PRODUCTION. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S88). Retrieved from https://www.webofscience.com/
ROLE OF THE PODOCYTES IN BIOMARKER PRODUCTION IN JUVENILE LUPUS NEPHRITIS
Wright, R., & Beresford, M. W. (2016). ROLE OF THE PODOCYTES IN BIOMARKER PRODUCTION IN JUVENILE LUPUS NEPHRITIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S72). Retrieved from https://www.webofscience.com/
Rituximab Should be Considered in Rheumatoid Factor Negative Poly-Articular Juvenile Idiopathic Arthritis
Sampath, S., McCann, L. J., Beresford, M. W., Baildam, E., Sergeant, J. C., Thomson, W., . . . Hyrich, K. L. (2016). Rituximab Should be Considered in Rheumatoid Factor Negative Poly-Articular Juvenile Idiopathic Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 68. Retrieved from https://www.webofscience.com/
STUDYING THE POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS FOR PHAGOCYTOSIS
Glaser, A., Wright, H. L., Wright, R. D., Midgley, A., Peak, M., & Beresford, M. W. (2016). STUDYING THE POTENTIAL OF NEUTROPHILS FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE) PATIENTS FOR PHAGOCYTOSIS. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 34 (pp. S57). Retrieved from https://www.webofscience.com/
2015
Juvenile-onset systemic lupus erythematosus: how to diagnose and manage
Oni, L., Thorbinson, C., & Beresford, M. W. (2015). Juvenile-onset systemic lupus erythematosus: how to diagnose and manage. Paediatrics and Child Health, 25(12), 555-560. doi:10.1016/j.paed.2015.07.005
Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis
Sampath, S., McCann, L. J., McDonagh, J., Cleary, G., Spinty, S., Pain, C. E., . . . Beresford, M. W. (2015). Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis. LUPUS, 24(13), 1462-1463. doi:10.1177/0961203315591030
Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study
Hawwa, A. F., AlBawab, A., Rooney, M., Wedderburn, L. R., Beresford, M. W., & McElnay, J. C. (2015). Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study. ARTHRITIS RESEARCH & THERAPY, 17. doi:10.1186/s13075-015-0814-z
Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use
McCann, L. J., Kirkham, J. J., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., . . . Beresford, M. W. (2015). Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use. TRIALS, 16. doi:10.1186/s13063-015-0784-0
DEMONSTRATION OF AN "EXCELLENT" BIOMARKER PANEL FOR IDENTIFYING ACTIVE LUPUS NEPHRITIS IN CHILDREN
Smith, E., Oni, L., Midgley, A., Ekdawy, D., Corkhill, R., Jones, C., . . . Beresford, M. W. (2015). DEMONSTRATION OF AN "EXCELLENT" BIOMARKER PANEL FOR IDENTIFYING ACTIVE LUPUS NEPHRITIS IN CHILDREN. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 331). doi:10.1136/annrheumdis-2015-eular.3352
DEVELOPMENT OF AN INTERNATIONALLY AGREED MINIMAL DATASET FOR JUVENILE DERMATOMYOSITIS (JDM) FOR CLINICAL AND RESEARCH USE
McCann, L., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., Williamson, P., . . . Beresford, M. W. (2015). DEVELOPMENT OF AN INTERNATIONALLY AGREED MINIMAL DATASET FOR JUVENILE DERMATOMYOSITIS (JDM) FOR CLINICAL AND RESEARCH USE. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 837-838). doi:10.1136/annrheumdis-2015-eular.2479
EFFECTS OF INTERFERON ALPHA ON NEUTROPHIL APOPTOSIS AND CASPASE 3 CLEAVAGE
Irwin, S., Midgley, A., & Beresford, M. W. (2015). EFFECTS OF INTERFERON ALPHA ON NEUTROPHIL APOPTOSIS AND CASPASE 3 CLEAVAGE. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 915). doi:10.1136/annrheumdis-2015-eular.3415
EXPLORING THE RELATIONSHIP OF URINARY VASCULAR CELL ADHESION MOLECULE-1 WITH LUPUS NEPHRITIS DISEASE ACTIVITY OVER TIME
Ekdawy, D., Smith, E., Oni, L., Midgley, A., Corkhill, R., Jones, C., . . . Beresford, M. (2015). EXPLORING THE RELATIONSHIP OF URINARY VASCULAR CELL ADHESION MOLECULE-1 WITH LUPUS NEPHRITIS DISEASE ACTIVITY OVER TIME. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 610). doi:10.1136/annrheumdis-2015-eular.4558
EXPRESSION OF LOW DENSITY GRANULOCYTES AND HISTONE CITRULLINATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS AND JUVENILE IDIOPATHIC ARTHRITIS
Ong, J., Midgley, A., & Beresford, M. (2015). EXPRESSION OF LOW DENSITY GRANULOCYTES AND HISTONE CITRULLINATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS AND JUVENILE IDIOPATHIC ARTHRITIS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 146). doi:10.1136/annrheumdis-2015-eular.5002
FINAL EVIDENCE-BASED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF PAEDIATRIC VASCULITIDES
De Graeff, N., Groot, N., Kamphuis, S., Avcin, T., Bader-Meunier, B., Dolezalova, P., . . . Beresford, M. (2015). FINAL EVIDENCE-BASED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF PAEDIATRIC VASCULITIDES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 522-523). doi:10.1136/annrheumdis-2015-eular.6334
INHIBITION OF IFN ALPHA SIGNALLING REDUCES HMGB1 TRANSLOCATION AND NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE)
Midgley, A., & Beresford, M. W. (2015). INHIBITION OF IFN ALPHA SIGNALLING REDUCES HMGB1 TRANSLOCATION AND NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS (JSLE). In ANNALS OF THE RHEUMATIC DISEASES Vol. 74 (pp. 204-205). doi:10.1136/annrheumdis-2015-eular.5537
DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY
Smith, E. M. D., Corkhill, R., Midgley, A., Watson, L., Jones, C., Marks, S. D., . . . Beresford, M. W. (2015). DEVELOPING A URINARY BIOMARKER PANEL FOR MONITORING LUPUS NEPHRITIS DISEASE ACTIVITY. In RHEUMATOLOGY Vol. 54 (pp. 3). doi:10.1093/rheumatology/keu492
FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JIA: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS
Kearsley-Fleet, L., Davies, R., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2015). FACTORS ASSOCIATED WITH CHOICE OF FIRST BIOLOGIC AMONG CHILDREN WITH JIA: A COMBINED ANALYSIS FROM TWO UK PAEDIATRIC BIOLOGIC REGISTERS. In RHEUMATOLOGY Vol. 54 (pp. 5). doi:10.1093/rheumatology/keu494
FELTY'S SYNDROME IN RHEUMATOID FACTOR POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: THE ROLE OF RITUXIMAB
Brown, L. E., Sampath, S., Ryan, F., Pain, C. E., McCann, L. J., Cleary, G., . . . Baildam, E. M. (2015). FELTY'S SYNDROME IN RHEUMATOID FACTOR POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: THE ROLE OF RITUXIMAB. In RHEUMATOLOGY Vol. 54 (pp. 7). doi:10.1093/rheumatology/keu499
JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS WITH OVERLAP FEATURES OF ANCA-ASSOCIATED VASCULITIS : A CASE REPORT
Brown, L. E., Sampath, S., Ryan, F., Cleary, G., McCann, L., Pain, C., . . . Baildam, E. (2015). JUVENILE-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS WITH OVERLAP FEATURES OF ANCA-ASSOCIATED VASCULITIS : A CASE REPORT. In RHEUMATOLOGY Vol. 54 (pp. 11). doi:10.1093/rheumatology/keu508
Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus
Ballantine, L., Midgley, A., Harris, D., Richards, E., Burgess, S., & Beresford, M. W. (2015). Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus. PEDIATRIC RHEUMATOLOGY, 13. doi:10.1186/s12969-015-0007-y
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa
Hampson, L. V., Whitehead, J., Eleftheriou, D., Tudur-Smith, C., Jones, R., Jayne, D., . . . Brogan, P. A. (2015). Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa. PLOS ONE, 10(3). doi:10.1371/journal.pone.0120981
The development and assessment of biological treatments for children
Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2015). The development and assessment of biological treatments for children. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 79(3), 379-394. doi:10.1111/bcp.12406
Characterization of Human Disease Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1
Crow, Y. J., Chase, D. S., Schmidt, J. L., Szynkiewicz, M., Forte, G. M. A., Gornall, H. L., . . . Rice, G. I. (2015). Characterization of Human Disease Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 167(2), 296-312. doi:10.1002/ajmg.a.36887
Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature
Chiewchengchol, D., Murphy, R., Edwards, S. W., & Beresford, M. W. (2015). Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. PEDIATRIC RHEUMATOLOGY, 13. doi:10.1186/1546-0096-13-1
AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN
Smith, E. M. D. D., Oni, L., Midgley, A., Tullus, K., Pilkington, C., Marks, S., . . . Beresford, M. W. (2015). AN EXCELLENT BIOMARKER PANEL FOR IDENTIFICATION OF ACTIVE LUPUS NEPHRITIS IN CHILDREN. In NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 30. doi:10.1093/ndt/gfv153.5
Connective tissue diseases in children
Wedderburn, L. R., Pilkington, C. A., & Beresford, M. W. (2015). Connective tissue diseases in children. In Rheumatology (pp. 868-875). Elsevier. doi:10.1016/b978-0-323-09138-1.00105-4
Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use
McCann, L. J., Wedderburn, L. R., Pilkington, C., Huber, A. M., Ravelli, A., Kirkham, J., . . . Beresford, M. W. (2015). Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
NGS Panel for the Detection of Monogenic SLE in Children: Initial Results
Belot, A., Rice, G., Mathieu, A. -L., Bader-Meunier, B., Walzer, T., Briggs, T. A., . . . Crow, Y. (2015). NGS Panel for the Detection of Monogenic SLE in Children: Initial Results. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
RESPONSE TO RITUXIMAB IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM A NATIONAL MULTI-CENTRE REGISTER
Sutton, E. J., Watson, K. D., Isenberg, D. A., Rahman, A., Jayne, D., Gordon, C., . . . Bruce, I. N. (2015). RESPONSE TO RITUXIMAB IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM A NATIONAL MULTI-CENTRE REGISTER. In RHEUMATOLOGY Vol. 54 (pp. 30-31). Retrieved from https://www.webofscience.com/
THE RENAL STATUS OF THE UK JUVENILE-SLE COHORT
Oni, L., Richards, E., Smith, E., & Beresford, M. W. (2015). THE RENAL STATUS OF THE UK JUVENILE-SLE COHORT. In NEPHROLOGY DIALYSIS TRANSPLANTATION Vol. 30. doi:10.1093/ndt/gfv203.2
The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE
Watson, L., Beresford, M., Maynes, C., Pilkington, C., Marks, S. D., Glackin, Y., & Tullus, K. (2015). The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE. Lupus, 24(1), 10-17. doi:10.1177/0961203314547793
The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients
Chiewchengchol, D., Midgley, A., Sodsai, P., Deekajorndech, T., Hirankarn, N., Beresford, M. W., & Edwards, S. W. (2015). The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients. CLINICAL RHEUMATOLOGY, 34(1), 85-91. doi:10.1007/s10067-014-2800-2
2014
Population Pharmacokinetics of Teicoplanin in Children
Ramos-Martin, V., Paulus, S., Siner, S., Scott, E., Padmore, K., Newland, P., . . . Hope, W. W. (2014). Population Pharmacokinetics of Teicoplanin in Children. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 58(11), 6920-6927. doi:10.1128/AAC.03685-14
A COMPARISON OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AND THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS CLASSIFICATION CRITERIA
Lloyd, O., Heaf, E., Morgan, T., Roberts, C., McCann, L., & Beresford, M. W. (2014). A COMPARISON OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AND THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS CLASSIFICATION CRITERIA. In RHEUMATOLOGY Vol. 53 (pp. 13). Retrieved from https://www.webofscience.com/
A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE
Groot, N., Boom, V., de Graeff, N., Enders, F. B., ter Haar, N., Sperotto, F., . . . Wulffraat, N. M. (2014). A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE. In RHEUMATOLOGY Vol. 53 (pp. 13). Retrieved from https://www.webofscience.com/
A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE
Groot, N., Boom, V., de Graeff, N., Enders, F. B., ter Haar, N., Sperotto, F., . . . Wulffraat, N. M. (2014). A SYSTEMATIC LITERATURE REVIEW ON DIAGNOSIS AND TREATMENT OF PAEDIATRIC RHEUMATIC DISEASES: A SHARED INITIATIVE. In RHEUMATOLOGY Vol. 53 (pp. 22). Retrieved from https://www.webofscience.com/
BIOLOGIC CHOICES AFTER FIRST-LINE ANTI-TUMOUR NECROSIS FACTOR FAILURE IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
Richards, H., Baildam, E., McCann, L. J., Cleary, A. G., Beresford, M. W., & Pain, C. E. (2014). BIOLOGIC CHOICES AFTER FIRST-LINE ANTI-TUMOUR NECROSIS FACTOR FAILURE IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 8). Retrieved from https://www.webofscience.com/
IMPROVING CARE IN PAEDIATRIC RHEUMATIC DISEASES: THE SHARE PROJECT
Groot, N., Vastert, B., Wulffraat, N. M., & Beresford, M. W. (2014). IMPROVING CARE IN PAEDIATRIC RHEUMATIC DISEASES: THE SHARE PROJECT. In RHEUMATOLOGY Vol. 53 (pp. 22). Retrieved from https://www.webofscience.com/
IMPROVING CARE IN PAEDIATRIC RHEUMATOLOGIC DISEASES: THE SHARE PROJECT
Groot, N., Vastert, B., Wulffraat, N. M., & Beresford, M. W. (2014). IMPROVING CARE IN PAEDIATRIC RHEUMATOLOGIC DISEASES: THE SHARE PROJECT. In RHEUMATOLOGY Vol. 53 (pp. 12-13). Retrieved from https://www.webofscience.com/
INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS
Smith, E. M. D., Watson, L., Jones, C., Pilkington, C. A., Marks, S. D., Tullus, K., & Beresford, M. W. (2014). INVESTIGATING BIOMARKERS OF DISEASE ACTIVITY IN JUVENILE-ONSET LUPUS NEPHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 21). Retrieved from https://www.webofscience.com/
INVESTIGATING PHAGOCYTOSIS RECEPTORS IN SERUM FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHREMATOSUS PATIENTS
Burgess, S. L., Ballantine, L., Midgley, A., & Beresford, M. W. (2014). INVESTIGATING PHAGOCYTOSIS RECEPTORS IN SERUM FROM JUVENILE-ONSET SYSTEMIC LUPUS ERYTHREMATOSUS PATIENTS. In RHEUMATOLOGY Vol. 53 (pp. 21). Retrieved from https://www.webofscience.com/
THE EFFICACY OF RITUXIMAB IN JUVENILE-ONSET SLE: A RETROSPECTIVE COHORT STUDY
Watson, L., Maynes, C., Pilkington, C., Marks, S., Beresford, M. W., & Tullus, K. (2014). THE EFFICACY OF RITUXIMAB IN JUVENILE-ONSET SLE: A RETROSPECTIVE COHORT STUDY. In RHEUMATOLOGY Vol. 53 (pp. 14). Retrieved from https://www.webofscience.com/
THE PREVALENCE AND INTERPRETATION OF ANTIPHOSPHOLIPID ANTIBODIES IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS
Saleem, M. S., Simpson, D. L., Roberts, C. J., Ramanan, A. V., & Beresford, M. W. (2014). THE PREVALENCE AND INTERPRETATION OF ANTIPHOSPHOLIPID ANTIBODIES IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 53 (pp. 20). Retrieved from https://www.webofscience.com/
TWO CASES OF JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS WITH UNCOMMON ASSOCIATIONS AND CHALLENGES IN THERAPY
Sampath, S., Cleary, A. G., Pain, C. E., Baildam, E., Beresford, M. W., & McCann, L. J. (2014). TWO CASES OF JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS WITH UNCOMMON ASSOCIATIONS AND CHALLENGES IN THERAPY. In RHEUMATOLOGY Vol. 53 (pp. 11). Retrieved from https://www.webofscience.com/
USE OF RITUXIMAB IN RHEUMATOID FACTOR NEGATIVE JUVENILE RHEUMATOID ARTHRITIS
Sampath, S., Baildam, E., Cleary, A. G., Pain, C. E., Beresford, M. W., & McCann, L. J. (2014). USE OF RITUXIMAB IN RHEUMATOID FACTOR NEGATIVE JUVENILE RHEUMATOID ARTHRITIS. In RHEUMATOLOGY Vol. 53 (pp. 11). Retrieved from https://www.webofscience.com/
Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients
Chiewchengchol, D., Murphy, R., Morgan, T., Edwards, S. W., Leone, V., Friswell, M., . . . Grp, U. K. J. S. L. E. S. (2014). Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. RHEUMATOLOGY, 53(8), 1504-1512. doi:10.1093/rheumatology/keu137
Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research
McCann, L. J., Arnold, K., Pilkington, C. A., Huber, A. M., Ravelli, A., Beard, L., . . . Wedderburn, L. R. (2014). Developing a provisional, international Minimal Dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research. PEDIATRIC RHEUMATOLOGY, 12. doi:10.1186/1546-0096-12-31
New insights into the pathogenesis and management of lupus in children
Midgley, A., Watson, L., & Beresford, M. W. (2014). New insights into the pathogenesis and management of lupus in children. ARCHIVES OF DISEASE IN CHILDHOOD, 99(6), 563-567. doi:10.1136/archdischild-2013-304397
Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study
Watson, L., Tullus, K., Pilkington, C., Chesters, C., Marks, S., Newland, P., . . . Beresford, M. (2014). Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. Pediatric Nephrology, 29(3), 397-405. doi:10.1007/s00467-013-2668-4
Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study
Smith, E. M. D., Foster, H. E., Gray, W. K., Taylor-Robinson, D., & Beresford, M. W. (2014). Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study. RHEUMATOLOGY, 53(3), 557-561. doi:10.1093/rheumatology/ket402
A Novel Dried Blood Spot-LCMS Method for the Quantification of Methotrexate Polyglutamates as a Potential Marker for Methotrexate Use in Children
Hawwa, A. F., AlBawab, A., Rooney, M., Wedderburn, L. R., Beresford, M. W., & McElnay, J. C. (2014). A Novel Dried Blood Spot-LCMS Method for the Quantification of Methotrexate Polyglutamates as a Potential Marker for Methotrexate Use in Children. PLOS ONE, 9(2). doi:10.1371/journal.pone.0089908
The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus
Ballantine, L. E., Ong, J., Midgley, A., Watson, L., Flanagan, B., & Beresford, M. (2014). The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus. Pediatric Rheumatology, 12. doi:10.1186/1546-0096-12-4
A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis
Ramanan, A. V., Dick, A. D., McKay, A., Jones, A., Williamson, P., Compeyrot-Lacassagne, S., . . . Beresford, M. W. (2015). A Randomised Controlled Trial of the Clinical Effectiveness, Safety and Cost-Effectiveness of Adalimumab in Combination with Methotrexate for the Treatment of Juvenile Idiopathic Arthritis Associated Uveitis. ARTHRITIS & RHEUMATOLOGY, 67. Retrieved from https://www.webofscience.com/
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
Ramanan, A. V., Dick, A. D., Benton, D., Compeyrot-Lacassagne, S., Dawoud, D., Hardwick, B., . . . The SYCAMORE Trial Management Group. (2014). A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials, 15. doi:10.1186/1745-6215-15-14
Factors Associated with Choice of First Biologic Among Children with Juvenile Idiopathic Arthritis: A Combined Analysis from 2 UK Paediatric Biologic Registers.
Davies, R., Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Foster, H. E., Southwood, T. R., . . . Hyrich, K. L. (2014). Factors Associated with Choice of First Biologic Among Children with Juvenile Idiopathic Arthritis: A Combined Analysis from 2 UK Paediatric Biologic Registers.. ARTHRITIS & RHEUMATOLOGY, 66, S114-S115. Retrieved from https://www.webofscience.com/
Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling
Rice, G. I., Duany, Y. D. T., Jenkinson, E. M., Forte, G. M. A., Anderson, B. H., Ariaudo, G., . . . Crow, Y. J. (2014). Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. NATURE GENETICS, 46(5), 503-509. doi:10.1038/ng.2933
Methodology of clinical trials for rare diseases
Tudur Smith, C., Williamson, P. R., & Beresford, M. W. (2014). Methodology of clinical trials for rare diseases. Best Practice and Research: Clinical Rheumatology, 28(2), 247-262. doi:10.1016/j.berh.2014.03.004
Methodology of clinical trials for rare diseases
Smith, C. T., Williamson, P. R., & Beresford, M. W. (2014). Methodology of clinical trials for rare diseases. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 28(2), 247-262. doi:10.1016/j.berh.2014.03.004
Predictors of access to care in patients with juvenile systemic lupus erythematosus
Smith, E. M. D., Foster, H. E., Gray, W. K., Taylor-Robinson, D., & Beresford, M. W. (2014). Predictors of access to care in patients with juvenile systemic lupus erythematosus. BRITISH JOURNAL OF HOSPITAL MEDICINE, 75(2), 69. Retrieved from https://www.webofscience.com/
RELATIVE EXPRESSION OF KIDNEY-ASSOCIATED PROTEINS IN LUPUS NEPHRITIS: IDENTIFYING FUTURE URINARY BIOMARKER TARGETS FOR DISEASE MONITORING
Smith, E. M. D., Midgley, A., Watson, L., Jones, C., Pilkington, C., Marks, S. D., . . . Beresford, M. W. (2014). RELATIVE EXPRESSION OF KIDNEY-ASSOCIATED PROTEINS IN LUPUS NEPHRITIS: IDENTIFYING FUTURE URINARY BIOMARKER TARGETS FOR DISEASE MONITORING. In RHEUMATOLOGY Vol. 53 (pp. 183-184). Retrieved from https://www.webofscience.com/
Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register
Sutton, E., Watson, K. D., Isenberg, D. A., Rahman, A., Jayne, D., Gordon, C., . . . Bruce, I. N. (2014). Response to Rituximab in Patients with Refractory Systemic Lupus Erythematosus (SLE): Results from a National Multicentre Register. ARTHRITIS & RHEUMATOLOGY, 66, S295. Retrieved from https://www.webofscience.com/
USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY
Kearsley-Fleet, L., Baildam, E., Beresford, M., Davies, R., Foster, H. E., Mowbray, K., . . . Hyrich, K. L. (2014). USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY. In RHEUMATOLOGY Vol. 53 (pp. 169-170). Retrieved from https://www.webofscience.com/
2013
Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis
McErlane, F., Beresford, M. W., Baildam, E. M., Thomson, W., & Hyrich, K. L. (2013). Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis. RHEUMATOLOGY, 52(11), 1941-1951. doi:10.1093/rheumatology/ket150
International Consensus for Provisions of Quality-Driven Care in Childhood-Onset Systemic Lupus Erythematosus
Hollander, M. C., Sage, J. M., Greenler, A. J., Pendl, J., Avcin, T., Espada, G., . . . Brunner, H. I. (2013). International Consensus for Provisions of Quality-Driven Care in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 65(9), 1416-1423. doi:10.1002/acr.21998
Protein Kinase C Deficiency Causes Mendelian Systemic Lupus Erythematosus With B Cell-Defective Apoptosis and Hyperproliferation
Belot, A., Kasher, P. R., Trotter, E. W., Foray, A. -P., Debaud, A. -L., Rice, G. I., . . . Bonnefoy, N. (2013). Protein Kinase C Deficiency Causes Mendelian Systemic Lupus Erythematosus With B Cell-Defective Apoptosis and Hyperproliferation. ARTHRITIS AND RHEUMATISM, 65(8), 2161-2171. doi:10.1002/art.38008
How to use ... lupus anticoagulants
Sen, E. S., Beresford, M. W., Avcin, T., & Ramanan, A. V. (2013). How to use ... lupus anticoagulants. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 98(2), 52-57. doi:10.1136/archdischild-2012-302321
Urine biomarkers in juvenile-onset SLE nephritis
Watson, L., & Beresford, M. W. (2013). Urine biomarkers in juvenile-onset SLE nephritis. PEDIATRIC NEPHROLOGY, 28(3), 363-374. doi:10.1007/s00467-012-2184-y
Urine biomarkers in juvenile-onset SLE nephritis.
Watson, L., & Beresford, M. (2013). Urine biomarkers in juvenile-onset SLE nephritis.. Pediatric Nephrology, 28(3), 363-374.
Adding to complexity: comorbidity in paediatric rheumatic disease
Smith, E. M. D., Foster, H. E., & Beresford, M. W. (2013). Adding to complexity: comorbidity in paediatric rheumatic disease. RHEUMATOLOGY, 52(1), 22-33. doi:10.1093/rheumatology/kes256
Children and adolescents with SLE: not just little adults
Morgan, T. A., Watson, L., McCann, L. J., & Beresford, M. W. (2013). Children and adolescents with SLE: not just little adults. LUPUS, 22(12), 1309-1319. doi:10.1177/0961203313502863
MINIMAL DISEASE ACTIVITY IN A CLINICAL COHORT OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS PROSPECTIVE STUDY
McErlane, F., Beresford, M., Baildam, E., Chieng, S. E., Davidson, J., Foster, H. E., . . . Hyrich, K. (2013). MINIMAL DISEASE ACTIVITY IN A CLINICAL COHORT OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS PROSPECTIVE STUDY. In RHEUMATOLOGY Vol. 52 (pp. 119-120). Retrieved from https://www.webofscience.com/
NIHR Medicines for Children Research Network: improving children's health through clinical research
Rose, A. C., Van't Hoff, W., Beresford, M. W., & Tansey, S. P. (2013). NIHR Medicines for Children Research Network: improving children's health through clinical research. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 6(5), 581-587. doi:10.1586/17512433.2013.831531
Paediatric use of mycophenolate mofetil
Downing, H. J., Pirmohamed, M., Beresford, M. W., & Smyth, R. L. (2013). Paediatric use of mycophenolate mofetil. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 75(1), 45-59. doi:10.1111/j.1365-2125.2012.04305.x
USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY
Kearsley-Fleet, L., Baildam, E., Beresford, M. W., Davies, R., Foster, H. E., Mowbray, K., . . . Hyrich, K. L. (2013). USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY. In RHEUMATOLOGY Vol. 52 (pp. 118-119). Retrieved from https://www.webofscience.com/
Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis
Mcerlane, F., Beresford, M. W., Baildam, E. M., Chieng, S. E. A., Davidson, J. E., Foster, H. E., . . . Hyrich, K. L. (2013). Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. ANNALS OF THE RHEUMATIC DISEASES, 72(12), 1983-1988. doi:10.1136/annrheumdis-2012-202031
2012
Introduction
Pilkington, C., Beresford, M. W., Foster, H., & Walsh, J. (2012). Introduction. RHEUMATOLOGY, 51, 1. doi:10.1093/rheumatology/ket117
Increased Serum Concentration of Sphingosine-1-phosphate in Juvenile-onset Systemic Lupus Erythematosus
Watson, L., Tullus, K., Marks, S. D., Holt, R. C. L., Pilkington, C., & Beresford, M. W. (2012). Increased Serum Concentration of Sphingosine-1-phosphate in Juvenile-onset Systemic Lupus Erythematosus. JOURNAL OF CLINICAL IMMUNOLOGY, 32(5), 1019-1025. doi:10.1007/s10875-012-9710-3
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
Watson, L., Leone, V., Pilkington, C., Tullus, K., Rangaraj, S., McDonagh, J. E., . . . Beresford, M. (2012). Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.. Arthritis and Rheumatism, 64(7), 2356-2365.
Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort
Watson, L., Leone, V., Pilkington, C., Tullus, K., Rangaraj, S., McDonagh, J. E., . . . Beresford, M. W. (2012). Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort. ARTHRITIS AND RHEUMATISM, 64(7), 2356-2365. doi:10.1002/art.34410
Standard 5: Selection, Measurement, and Reporting of Outcomes in Clinical Trials in Children
Sinha, I. P., Altman, D. G., Beresford, M. W., Boers, M., Clarke, M., Craig, J., . . . Smyth, R. L. (2012). Standard 5: Selection, Measurement, and Reporting of Outcomes in Clinical Trials in Children. PEDIATRICS, 129, S146-S152. doi:10.1542/peds.2012-0055H
Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE
Midgley, A., Thorbinson, C., & Beresford, M. W. (2012). Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. RHEUMATOLOGY, 51(5), 824-832. doi:10.1093/rheumatology/ker400
Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE
Midgley, A., Thorbinson, C., & Beresford, M. W. (2012). Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE. Rheumatology, 51(5), 824-832. doi:10.1093/rheumatology/ker400
Juvenile idiopathic arthritis: Symptoms and diagnosis
Kelly, J., & Beresford, M. W. (2012). Juvenile idiopathic arthritis: Symptoms and diagnosis. British Journal of School Nursing, 7(3), 117-120. doi:10.12968/bjsn.2012.7.3.117
Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus
Watson, L., Midgley, A., Pilkington, C., Tullus, K., Marks, S. D., Holt, R. C. L., . . . Beresford, M. W. (2012). Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. LUPUS, 21(5), 496-501. doi:10.1177/0961203311431249
Henoch Schonlein Purpura - A 5-Year Review and Proposed Pathway
Watson, L., Richardson, A. R. W., Holt, R. C. L., Jones, C. A., & Beresford, M. W. (2012). Henoch Schonlein Purpura - A 5-Year Review and Proposed Pathway. PLOS ONE, 7(1). doi:10.1371/journal.pone.0029512
A NOVEL ASSAY FOR DETECTING NITRATED NUCLEOSOMES: A POTENTIAL SURROGATE BIOMARKER FOR JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
Pericleous, C., Croca, S. C., Giles, I., Alber, K., Yong, H., Isenberg, D., . . . Ioannou, Y. (2012). A NOVEL ASSAY FOR DETECTING NITRATED NUCLEOSOMES: A POTENTIAL SURROGATE BIOMARKER FOR JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 51 (pp. 110). Retrieved from https://www.webofscience.com/
A novel method for investigating macrophage phagocytosis in juvenile systemic lupus erythematosus using the pH sensitive dye pHRodo
Ballantine, L., Harris, D., & Beresford, M. W. (2012). A novel method for investigating macrophage phagocytosis in juvenile systemic lupus erythematosus using the pH sensitive dye pHRodo. In IMMUNOLOGY Vol. 137 (pp. 571). Retrieved from https://www.webofscience.com/
DOES EXCLUSION OF THE ESR FROM JADAS AFFECT VALIDITY IN THE ROUTINE CLINICAL SETTING?
McErlane, F., Beresford, M. W., Baildam, E. M., Thomson, W., Hyrich, K., Chieng, A., . . . Wedderburn, L. (2012). DOES EXCLUSION OF THE ESR FROM JADAS AFFECT VALIDITY IN THE ROUTINE CLINICAL SETTING?. In RHEUMATOLOGY Vol. 51 (pp. 109). Retrieved from https://www.webofscience.com/
Henoch schonlein purpura--a 5-year review and proposed pathway
Watson, L., Richardson, A. R. W., Holt, R. C. L., Jones, C. A., & Beresford, M. (2012). Henoch schonlein purpura--a 5-year review and proposed pathway. PloS one, 7(1).
Inactive Disease and Remission in Childhood-Onset Systemic Lupus Erythematosus
Mina, R., Klein-Gitelman, M. S., Ravelli, A., Beresford, M. W., Avcin, T., Espada, G., . . . Brunner, H. I. (2012). Inactive Disease and Remission in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 64(5), 683-693. doi:10.1002/acr.21612
Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus
Watson, L., Tullus, K., Marks, S. D., Holt, R. C. L., Pilkington, C., & Beresford, M. W. (2012). Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus. J Clin Immunol, 32(5), 1019-1025.
NOVEL URINARY BIOMARKERS OUTPERFORM STANDARD BIOMARKERS IN JUVENILE LUPUS NEPHRITIS: A PROSPECTIVE LONGITUDINAL VALIDATION STUDY
Watson, L., Tullus, K., Pilkington, C., Chesters, C., Marks, S. D., Newland, P., . . . Beresford, M. W. (2012). NOVEL URINARY BIOMARKERS OUTPERFORM STANDARD BIOMARKERS IN JUVENILE LUPUS NEPHRITIS: A PROSPECTIVE LONGITUDINAL VALIDATION STUDY. In RHEUMATOLOGY Vol. 51 (pp. 2). Retrieved from https://www.webofscience.com/
PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY
Smith, E., Gray, W., Taylor-Robinson, D., Foster, H. E., & Beresford, M. W. (2012). PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8-9). Retrieved from https://www.webofscience.com/
PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY
Smith, E., Gray, W., Taylor-Robinson, D., Foster, H. E., & Beresford, M. W. (2012). PREDICTORS OF ACCESS TO CARE IN JSLE: EVIDENCE FROM THE UK JSLE COHORT STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8-9). Retrieved from https://www.webofscience.com/
PREVALENCE AND SIGNIFICANCE OF THROMBOCYTOPENIA IN JUVENILE ONSET SLE AT PRESENTATION AND 1-YEAR FOLLOW-UP
Gohar, F., Watson, L., & Beresford, M. W. (2012). PREVALENCE AND SIGNIFICANCE OF THROMBOCYTOPENIA IN JUVENILE ONSET SLE AT PRESENTATION AND 1-YEAR FOLLOW-UP. In RHEUMATOLOGY Vol. 51 (pp. 9). Retrieved from https://www.webofscience.com/
PREVALENCE AND SIGNIFICANCE OF THROMBOCYTOPENIA IN JUVENILE ONSET SLE AT PRESENTATION AND 1-YEAR FOLLOW-UP
Gohar, F., Watson, L., & Beresford, M. W. (2012). PREVALENCE AND SIGNIFICANCE OF THROMBOCYTOPENIA IN JUVENILE ONSET SLE AT PRESENTATION AND 1-YEAR FOLLOW-UP. In RHEUMATOLOGY Vol. 51 (pp. 9). Retrieved from https://www.webofscience.com/
Standards for child health trial design, conduct and reporting: Standard 5: Selection, measurement and reporting of outcomes
Sinha, I. P., Altman, D., Beresford, M. W., Boers, M., Clarke, M., Craig, J., . . . Smyth, R. L. (2012). Standards for child health trial design, conduct and reporting: Standard 5: Selection, measurement and reporting of outcomes. Pediatrics, 129(Suppl), 146-152.
Stimulation of Juvenile systemic lupus erythematosus blood cells induces IL-17 production
Ballantine, L., Ong, J., Midgley, A., Watson, L., & Beresford, M. W. (2012). Stimulation of Juvenile systemic lupus erythematosus blood cells induces IL-17 production. IMMUNOLOGY, 137, 259. Retrieved from https://www.webofscience.com/
USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JIA: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY
Kearsley-Fleet, L., Baildam, E., Beresford, M., Davies, R., Foster, H. E., Mowbray, K., . . . Hyrich, K. L. (2012). USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JIA: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8). Retrieved from https://www.webofscience.com/
USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JIA: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY
Kearsley-Fleet, L., Baildam, E., Beresford, M., Davies, R., Foster, H. E., Mowbray, K., . . . Hyrich, K. L. (2012). USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JIA: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY. In RHEUMATOLOGY Vol. 51 (pp. 8). Retrieved from https://www.webofscience.com/
Urinary Monocyte Chemoattractant protein 1 and Alpha-1-acid glycoprotein as biomarkers of renal disease activity in Juvenile-onset Systemic Lupus Erythematosus
Watson, L., Midgley, A., Pilkington, C., Tullus, K., Holt, R. L., Marks, S., . . . Beresford, M. W. (2012). Urinary Monocyte Chemoattractant protein 1 and Alpha-1-acid glycoprotein as biomarkers of renal disease activity in Juvenile-onset Systemic Lupus Erythematosus. Lupus, 21, 496-501.
VALIDATION OF JADAS IN ALL SUBTYPES OF JUVENILE IDIOPATHIC ARTHRITIS IN A CLINICAL SETTING
McErlane, F., Beresford, M. W., Baildam, E. M., Thomson, W., Hyrich, K., Chieng, A., . . . Wedderburn, L. (2012). VALIDATION OF JADAS IN ALL SUBTYPES OF JUVENILE IDIOPATHIC ARTHRITIS IN A CLINICAL SETTING. In RHEUMATOLOGY Vol. 51 (pp. 27). Retrieved from https://www.webofscience.com/
WHY IS IT IMPORTANT TO KNOW ABOUT LUPUS IN CHILDREN?
Beresford, M. W. (2012). WHY IS IT IMPORTANT TO KNOW ABOUT LUPUS IN CHILDREN?. In RHEUMATOLOGY Vol. 51 (pp. 13). Retrieved from https://www.webofscience.com/
2011
Diagnosis and management of juvenile-onset SLE
Watson, L., Gohar, F., & Beresford, M. W. (2011). Diagnosis and management of juvenile-onset SLE. Paediatrics and Child Health, 21(12), 539-545. doi:10.1016/j.paed.2011.06.005
Needle-free and microneedle drug delivery in children: A case for disease-modifying antirheumatic drugs (DMARDs)
Shah, U. U., Roberts, M., Gul, M. O., Tuleu, C., & Beresford, M. W. (2011). Needle-free and microneedle drug delivery in children: A case for disease-modifying antirheumatic drugs (DMARDs). INTERNATIONAL JOURNAL OF PHARMACEUTICS, 416(1), 1-11. doi:10.1016/j.ijpharm.2011.07.002
Preliminary Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus
Brunner, H. I., Mina, R., Pilkington, C., Beresford, M. W., Reiff, A., Levy, D. M., . . . Giannini, E. H. (2011). Preliminary Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus. ARTHRITIS CARE & RESEARCH, 63(9), 1213-1223. doi:10.1002/acr.20507
Communication about Children's Clinical Trials as Observed and Experienced: Qualitative Study of Parents and Practitioners
Shilling, V., Williamson, P. R., Hickey, H., Sowden, E., Beresford, M. W., Smyth, R. L., & Young, B. (2011). Communication about Children's Clinical Trials as Observed and Experienced: Qualitative Study of Parents and Practitioners. PLOS ONE, 6(7). doi:10.1371/journal.pone.0021604
Juvenile Idiopathic Arthritis New Insights into Classification, Measures of Outcome, and Pharmacotherapy
Beresford, M. W. (2011). Juvenile Idiopathic Arthritis New Insights into Classification, Measures of Outcome, and Pharmacotherapy. PEDIATRIC DRUGS, 13(3), 161-173. doi:10.2165/11588140-000000000-00000
Cellular localization of nuclear antigen during neutrophil apoptosis: mechanism for autoantigen exposure?
Midgley, A., & Beresford, M. W. (2011). Cellular localization of nuclear antigen during neutrophil apoptosis: mechanism for autoantigen exposure?. LUPUS, 20(6), 641-646. doi:10.1177/0961203310392421
Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature
Briggs, T. A., Rice, G. I., Daly, S., Urquhart, J., Gornall, H., Bader-Meunier, B., . . . Crow, Y. J. (2011). Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. NATURE GENETICS, 43(2), 127-U71. doi:10.1038/ng.748
Achieving Consensus on Quality Indicators for Pediatric Systemic Lupus Erythematosus
Pendl, J. D., Hollander, M. C., Nelson, S. L., Morgan, X., Ruperto, N., Beresford, M. W., . . . Brunner, H. (2011). Achieving Consensus on Quality Indicators for Pediatric Systemic Lupus Erythematosus. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S236-S237). Retrieved from https://www.webofscience.com/
Autoantibody Testing for Children on Biologic Therapies for Rheumatological Conditions: Results of Audit
Duncan, J., Heath, J., Baildam, E. M., Cleary, G., Beresford, M. W., & McCann, L. J. (2011). Autoantibody Testing for Children on Biologic Therapies for Rheumatological Conditions: Results of Audit. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S791). Retrieved from https://www.webofscience.com/
Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners
Shilling, V., Williamson, P. R., Hickey, H., Sowden, E., Beresford, M. W., Smyth, R. L., & Young, B. (2011). Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners. PLoS One, 6(7), e21604.
Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in Juvenile Systemic Lupus Erythematosus: The role of caspases.
Midgley, A. M., Mayer, K., Edwards, S. W., & Beresford, M. W. (2011). Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in Juvenile Systemic Lupus Erythematosus: The role of caspases.. Lupus, 20(1), 71.
Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in juvenile systemic lupus erythematosus
Midgley, A., Mayer, K., Edwards, S. W., & Beresford, M. W. (2011). Differential expression of factors involved in the intrinsic and extrinsic apoptotic pathways in juvenile systemic lupus erythematosus. LUPUS, 20(1), 71-79. doi:10.1177/0961203310382128
International consensus for a definition of disease flare in lupus.
Ruperto, N., Hanrahan, L. M., Alarcón, G. S., Belmont, H. M., Brey, R. L., Brunetta, P., . . . al., E. (2011). International consensus for a definition of disease flare in lupus.. Lupus, 13(3), 453-462.
Investigating children's beliefs about Juvenile Arthritis: A Study Using Cognitive Interviewing.
Ghio, D., Thomson, W., Baildam, E. M., Hyrich, K., Beresford, M. W., Lydon, C., . . . Cordingley, L. (2011). Investigating children's beliefs about Juvenile Arthritis: A Study Using Cognitive Interviewing.. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S108-S109). Retrieved from https://www.webofscience.com/
Paediatric Connective Tissue Disorders
Wedderburn, L. R., Pilkington, C. A., & Beresford, M. W. (2011). Paediatric Connective Tissue Disorders. In M. Hochberg, A. J. Silman, J. S. Smolen, M. E. Weinblatt, & M. H. Weisman (Eds.), Rheumatology, 5th Edition (pp. 1035-1043). PA, USA: Elsevier,.
Th17 associated proteins in Juvenile systemic lupus erythematosus
Ballantine, L., Midgley, A., Watson, L., & Beresford, M. (2011). Th17 associated proteins in Juvenile systemic lupus erythematosus. In IMMUNOLOGY Vol. 135 (pp. 147). Retrieved from https://www.webofscience.com/
2010
Comment on: Developing standards of care for patients with juvenile idiopathic arthritis
Beresford, M. W., Cleary, A. G., Foster, H. E., Hutchinson, E., Baildam, E. M., & Davies, K. (2010). Comment on: Developing standards of care for patients with juvenile idiopathic arthritis. RHEUMATOLOGY, 49(11), 2227-2229. doi:10.1093/rheumatology/keq215
A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility
Kemp, S., Roberts, I., Gamble, C., Wilkinson, S., Davidson, J. E., Baildam, E. M., . . . Beresford, M. W. (2010). A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility. RHEUMATOLOGY, 49(2), 315-325. doi:10.1093/rheumatology/kep362
A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre
Gargh, K., Baildam, E. M., Cleary, G. A., Beresford, M. W., & McCann, L. J. (2010). A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre. RHEUMATOLOGY, 49(1), 193-194. doi:10.1093/rheumatology/kep309
DIFFERENTIAL EXPRESSION OF FACTORS INVOLVED IN THE EXTRINSIC APOPTOTIC PATHWAY IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS
Midgley, A. J., & Beresford, M. W. (2010). DIFFERENTIAL EXPRESSION OF FACTORS INVOLVED IN THE EXTRINSIC APOPTOTIC PATHWAY IN JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS. In RHEUMATOLOGY Vol. 49 (pp. I43-I44). Retrieved from https://www.webofscience.com/
Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus. Cochrane Database of Systematic Reviews
Craig, J. V., Pain, C. E., & Beresford, M. W. (2010). Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews, Issue.
2009
New advances in the management of juvenile idiopathic arthritis-1: Non-biological therapy
Beresford, M. W., & Baildam, E. M. (2009). New advances in the management of juvenile idiopathic arthritis-1: Non-biological therapy. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 94(5), 144-150. doi:10.1136/adc.2008.144576
New advances in the management of juvenile idiopathic arthritis-2: The era of biologicals
Beresford, M. W., & Baildam, E. M. (2009). New advances in the management of juvenile idiopathic arthritis-2: The era of biologicals. ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 94(5), 151-156. doi:10.1136/adc.2009.170860
The Role of Neutrophil Apoptosis in Juvenile-Onset Systemic Lupus Erythematosus
Midgley, A., McLaren, Z., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2009). The Role of Neutrophil Apoptosis in Juvenile-Onset Systemic Lupus Erythematosus. ARTHRITIS AND RHEUMATISM, 60(8), 2390-2401. doi:10.1002/art.24634
"To find the right answers, you need to ask the right questions." Consumer involvement in setting our research agenda
Hill, H., Kelly, J., Kemp, S., Baildam, E., Cleary, A. G., McCann, L., & Beresford, M. W. (2009). "To find the right answers, you need to ask the right questions." Consumer involvement in setting our research agenda. Rheumatology, Pendin, Pending.
DELAY TO DIAGNOSIS IN JUVENILE SLE (JSLE) PATIENTS: PRELIMINARY DATA FROM THE UK JSLE COHORT STUDY
Pain, C., Gardner-Medwin, J., McDonagh, J., Pilkington, C., Satyapal, R., Tizard, J., . . . Beresford, M. W. (2009). DELAY TO DIAGNOSIS IN JUVENILE SLE (JSLE) PATIENTS: PRELIMINARY DATA FROM THE UK JSLE COHORT STUDY. RHEUMATOLOGY, 48, I46. Retrieved from https://www.webofscience.com/
Decreased expression of proteins that inhibit apoptosis in patients with JSLE compared to controls.
Midgley, A. J., & Beresford, M. W. (2009). Decreased expression of proteins that inhibit apoptosis in patients with JSLE compared to controls.. Rheumatology (accepted for BSR 2009), Pendin, Pending.
IMBALANCE OF PRO AND ANTI APOPTOTIC FACTORS IN PATIENTS WITH JSLE COMPARED TO CONTROLS
Midgley, A. J., & Beresford, M. W. (2009). IMBALANCE OF PRO AND ANTI APOPTOTIC FACTORS IN PATIENTS WITH JSLE COMPARED TO CONTROLS. In RHEUMATOLOGY Vol. 48 (pp. I31-I32). Retrieved from https://www.webofscience.com/
INCREASED CD80 AND CD86 IN THE SERUM OF PATIENTS WITH JSLE COMPARED TO CONTROLS
Midgley, A. J., & Beresford, M. W. (2009). INCREASED CD80 AND CD86 IN THE SERUM OF PATIENTS WITH JSLE COMPARED TO CONTROLS. In RHEUMATOLOGY Vol. 48 (pp. I34). Retrieved from https://www.webofscience.com/
Increased CD80 and CD86 in the serum of patients with JSLE compared to controls
Midgley, A., & Beresford, M. W. (2009). Increased CD80 and CD86 in the serum of patients with JSLE compared to controls. Rheumatology (accepted for BSR 2009), Pendin, Pending.
2008
The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to juvenile systemic lupus erythematosus serum can reduce abnormal neutrophil apoptosis
Midgley, A. J., McLaren, Z., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to juvenile systemic lupus erythematosus serum can reduce abnormal neutrophil apoptosis. Pediatric Rheumatology, 6(S1). doi:10.1186/1546-0096-6-s1-p232
UK paediatric rheumatology and its clinical trials network
Beresford, M. W., Baildam, E. M., Brogan, P. A., Foster, H. E., Ramanan, A. V., Rooney, M. E., . . . Woo, P. (2008). UK paediatric rheumatology and its clinical trials network. Pediatric Rheumatology, 6(S1). doi:10.1186/1546-0096-6-s1-p150
Arthropathy in paediatric inflammatory bowel disease: a cross-sectional observational study
McErlane, F., Gillon, C., Irvine, T., Davidson, J. E., Casson, D., Dalzell, A. M., & Beresford, M. W. (2008). Arthropathy in paediatric inflammatory bowel disease: a cross-sectional observational study. RHEUMATOLOGY, 47(8), 1251-1252. doi:10.1093/rheumatology/ken217
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis
Thornton, J., Lunt, M., Ashcroft, D. M., Baildam, E., Foster, H., Davidson, J., . . . Elliott, R. A. (2008). Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. RHEUMATOLOGY, 47(7), 985-990. doi:10.1093/rheumatology/ken039
Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group
Thornton, J., Beresford, M. W., & Clayton, P. (2008). Improving the evidence base for treatment of juvenile idiopathic arthritis: the challenge and opportunity facing the MCRN/ARC Paediatric Rheumatology Clinical Studies Group. RHEUMATOLOGY, 47(5), 563-566. doi:10.1093/rheumatology/ken055
A new new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (arc) Clinical Studies Groups Initiative
Silman, A. (2008). A new new paradigm for musculoskeletal clinical trials in the UK: the Arthritis Research Campaign (arc) Clinical Studies Groups Initiative. Rheumatology.
Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis
Thornton, J., Lunt, M., Ashcroft, D. M., Baildam, E., Foster, H., Davidson, J., . . . Elliott, R. A. (2008). Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis. Rheumatology, Advanced publication 160408.
Increased neutrophil apoptosis may be associated with decreased levels of IL-6, GM-CSF and TNF-alpha concentrations in JSLE serum compared to controls
Midgley, A. J., McLaren, Z., Moots, R. J., Edwards, S. E., & Beresford, M. W. (2008). Increased neutrophil apoptosis may be associated with decreased levels of IL-6, GM-CSF and TNF-alpha concentrations in JSLE serum compared to controls. 3rd International Conference on Cytokine Medicine., *(*), *.
Inducing apoptosis: Increased TRAIL and FasL concentrations in JSLE serum compared to controls
Midgley, A. J., McLaren, Z. L., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). Inducing apoptosis: Increased TRAIL and FasL concentrations in JSLE serum compared to controls. Lupus, 17(5), suppl:495.
Modulation of the immune inhibitory pathway: Increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression
Midgley, A. J., & Beresford, M. W. (2008). Modulation of the immune inhibitory pathway: Increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression. Immunology, 125, (suppl 1):OP173.
Modulation of the immune inhibitory pathway: increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression
Midgley, A., Motaal, A., & Beresford, M. (2008). Modulation of the immune inhibitory pathway: increased expression of TLR's in JSLE lymphocytes correlates with decreased FoxP3 expression. In IMMUNOLOGY Vol. 125 (pp. 129). Retrieved from https://www.webofscience.com/
Peripheral T-Cell lymphoma in a five year old
Beresford, M. W., Wilkins, S., Ashworth, M., Davidson, J. E., McDowell, H., & Cleary, A. G. (2008). Peripheral T-Cell lymphoma in a five year old. PEDIATRIC BLOOD & CANCER, 50(1), 145-147. doi:10.1002/pbc.21055
Role of Neutrophil Apoptosis in Juvenile-onset SLE
McLaren, Z. L., Midgley, A. J., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). Role of Neutrophil Apoptosis in Juvenile-onset SLE. Rheumatology, 47, (suppl 2):ii94(320).
Steroid use in the management of acute juvenile systemic lupus erythematosus - A National Survey
McLaren, Z. L., Beresford, M. W., & on, B. O. U. J. S. G. (2008). Steroid use in the management of acute juvenile systemic lupus erythematosus - A National Survey. Rheumatology, 47, (suppl 2):ii27(89).
Steroid use in the management of acute juvenile systemic lupus erythematosus - A national survey
McLaren, Z. L., & Beresford, M. W. (2008). Steroid use in the management of acute juvenile systemic lupus erythematosus - A national survey. In RHEUMATOLOGY Vol. 47 (pp. II27). Retrieved from https://www.webofscience.com/
The Role of Neutrophil Apoptosis in Juvenile-onset Systemic Lupus Erythematosus
Midgley, A., McLaren, Z., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). The Role of Neutrophil Apoptosis in Juvenile-onset Systemic Lupus Erythematosus. ACR Pediatric Rheumatology Symposium, Keystone 2008, Awaite, Abstract 124.
The role of neutrophil apoptosis in juvenile systemic lupus erythematosus
McLaren, Z. L., Midgley, A., Moots, R. J., Edwards, S. W., & Beresford, M. W. (2008). The role of neutrophil apoptosis in juvenile systemic lupus erythematosus. In RHEUMATOLOGY Vol. 47 (pp. II94). Retrieved from https://www.webofscience.com/
2007
Acrimonious acronyms: CRMO, SAPHO and a sore shin (vol 122, pg 252, 2007)
Beresford, M. W., Deutschmann, A., & Sullivan, K. E. (2007). Acrimonious acronyms: CRMO, SAPHO and a sore shin (vol 122, pg 252, 2007). CLINICAL IMMUNOLOGY, 124(3), 353. doi:10.1016/j.clim.2006.11.011
ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency
Olsen, R. K. J., Olpin, S. E., Andresen, B. S., Miedzybrodzka, Z. H., Pourfarzam, M., Merinero, B., . . . Morris, A. A. M. (2007). ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. BRAIN, 130, 2045-2054. doi:10.1093/brain/awm135
Neonatal lupus syndrome
Pain, C., & Beresford, M. W. (2007). Neonatal lupus syndrome. Paediatrics and Child Health, 17(6), 223-227. doi:10.1016/j.paed.2007.03.002
Acrimonious acronyms: CRMO, SAPHO and a sore shin
Beresford, M. W., Deautschmann, A., & Sullivan, K. E. (2007). Acrimonious acronyms: CRMO, SAPHO and a sore shin. CLINICAL IMMUNOLOGY, 122(3), 252-254. doi:10.1016/j.clim.2006.11.006
Development of a national multi-centre, multi-disciplinary collaborative registry & repository of patients with juvenile-onset SLE
Beresford, M. W. (2007). Development of a national multi-centre, multi-disciplinary collaborative registry & repository of patients with juvenile-onset SLE. Lupus, 16 (su, 49.
Juvenile-onset Lupus
Beresford, M. W. (2007). Juvenile-onset Lupus. In Y. Norton (Ed.), Lupus: GP Guide to Diagnosis (pp. Awaited). London: Lupus UK.
2006
So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager
Beresford, M. W., Pourfarzam, M., & Davidson, J. E. (2006). So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager. NEUROMUSCULAR DISORDERS, 16(9-10), 613. doi:10.1016/j.nmd.2006.07.003
Adolescent development and SLE
Beresford, M. W., & Davidson, J. E. (2006). Adolescent development and SLE. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 20(2), 353-368. doi:10.1016/j.berh.2005.11.003
So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager
Beresford, M. W., Pourfarzam, M., Turnbull, D. M., & Davidson, J. E. (2006). So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager. NEUROMUSCULAR DISORDERS, 16(4), 269-273. doi:10.1016/j.nmd.2006.01.001
Acute life threatening events among infants on home oxygen
Harrison, G., Beresford, M. W., & Shaw, N. (2006). Acute life threatening events among infants on home oxygen. Paediatric Nursing, 18(2), 27-29.
2005
Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant?
Harling, A. E., Beresford, M. W., Vince, G. S., Bates, M., & Yoxall, C. W. (2005). Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant?. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 90(5), F406-F410. doi:10.1136/adc.2004.059303
Does the use of 50% oxygen at birth in preterm infants reduce lung injury?
Harling, A. E., Beresford, M. W., Vince, G. S., Bates, M., & Yoxall, C. W. (2005). Does the use of 50% oxygen at birth in preterm infants reduce lung injury?. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 90(5), F401-F405. doi:10.1136/adc.2004.059287
Arthropathy in children with inflammatory bowel disease: a cross-sectional observational study
Erlane, F., Gillon, C., Irvine, T., Beresford, M. W., & Davidson, J. (2005). Arthropathy in children with inflammatory bowel disease: a cross-sectional observational study. Arch Dis Child, 90 (s2, A52.
Cardiopulmonary involvement in juvenile systemic lupus erythematosus
Beresford, M. W., Cleary, A. G., Sills, J. A., Couriel, J., & Davidson, J. E. (2005). Cardiopulmonary involvement in juvenile systemic lupus erythematosus. Lupus, 14(1), 152-158.
Clinical presentation and subsequent manifestations of juvenile-onset SLE in the UK
Beresford, M. W., Hernandez, T., McDonagh, J., Ryder, C. A. J., & Davidson, J. E. (2005). Clinical presentation and subsequent manifestations of juvenile-onset SLE in the UK. Lupus, 14, 259.
Delayed diagnosis: JIA in children with learning difficulties
Beresford, M. W., Cleary, G., Sills, J. A., & Davidson, J. E. (2005). Delayed diagnosis: JIA in children with learning difficulties. RHEUMATOLOGY, 44, I121. Retrieved from https://www.webofscience.com/
Evaluation of a limping child
Beresford, M. W., & Cleary, A. G. (2005). Evaluation of a limping child. Current Paediatrics, 15(1), 15-22. doi:10.1016/j.cupe.2004.10.004
Paediatric blood monitoring on methotrexate: How often are results abnormal?
Kelly, J., Cleary, A. G., Davidson, J. E., Sills, J., & Beresford, M. W. (2005). Paediatric blood monitoring on methotrexate: How often are results abnormal?. Clin Exp Rheumatol, 23 sup, S75.
Peripheral T-cell lymphoma: Important differential diagnosis of panniculitis in 5 year old
Beresford, M. W., Ashworth, M., McErlane, F., Davidson, J. E., & Cleary, A. G. (2005). Peripheral T-cell lymphoma: Important differential diagnosis of panniculitis in 5 year old. Clin Exp Rheumatol, 23 sup, S76.
Twelve-month prospective study of oxygen saturation measurements among term and preterm infants.
Beresford, M. W., Parry, H., & Shaw, N. J. (2005). Twelve-month prospective study of oxygen saturation measurements among term and preterm infants.. Journal of perinatology : official journal of the California Perinatal Association, 25(1), 30-32. doi:10.1038/sj.jp.7211206
2004
Association of glutathione-S-transferase-P1 (GSTP1) polymorphism 105 Ile>val with chronic lung disease in preterm infants.
Cooke, R. W., Drury, J. A., Beresford, M. W., & Shaw, N. J. (2004). Association of glutathione-S-transferase-P1 (GSTP1) polymorphism 105 Ile>val with chronic lung disease in preterm infants.. Journal of perinatology : official journal of the California Perinatal Association, 24(12), 800. doi:10.1038/sj.jp.7211145
Pamidronate in the treatment of childhood SAPHO syndrome
Kerrison, C., Davidson, J. E., Cleary, A. G., & Beresford, M. W. (2004). Pamidronate in the treatment of childhood SAPHO syndrome. RHEUMATOLOGY, 43(10), 1246-1251. doi:10.1093/rheumatology/keh295
2003
Bronchoalveolar lavage surfactant protein A, B, and D concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants
Beresford, M. W., & Shaw, N. J. (2003). Bronchoalveolar lavage surfactant protein A, B, and D concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants. PEDIATRIC RESEARCH, 53(4), 663-670. doi:10.1203/01.PDR.0000054653.89527.F8
2002
Detectable IL-8 and IL-10 in Bronchoalveolar Lavage Fluid from Preterm Infants Ventilated for Respiratory Distress Syndrome
Beresford, M. W., & Shaw, N. J. (2002). Detectable IL-8 and IL-10 in Bronchoalveolar Lavage Fluid from Preterm Infants Ventilated for Respiratory Distress Syndrome. Pediatric Research, 52(6), 973-978. doi:10.1203/00006450-200212000-00025
Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome
Beresford, M. W., & Shaw, N. J. (2002). Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. PEDIATRIC RESEARCH, 52(6), 973-978. doi:10.1203/01.PDR.0000036626.67304.65
Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease
Beresford, M. W., Primhak, R., Subhedar, N. V., & Shaw, N. J. (2002). Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 87(1), F62-F63. doi:10.1136/fn.87.1.F62
Randomised, double blind, placebo controlled trail of inhaled fluticasone for chronic lung disease of prematurity.
Beresford, M. W., Primak, R., Subhedar, N. S., & Shaw, N. J. (2002). Randomised, double blind, placebo controlled trail of inhaled fluticasone for chronic lung disease of prematurity.. Arch Dis Child Fetal Neonatal Ed, 87(1), F62-F63.
2000
Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort
Clark, S. J., Beresford, M. W., Subhedar, N. V., & Shaw, N. J. (2000). Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort. ARCHIVES OF DISEASE IN CHILDHOOD, 83(4), 313-316. doi:10.1136/adc.83.4.313
Outcome of congenital diaphragmatic hernia
Beresford, M. W., & Shaw, N. J. (2000). Outcome of congenital diaphragmatic hernia. PEDIATRIC PULMONOLOGY, 30(3), 249-256. Retrieved from https://www.webofscience.com/
Pumactant and poractant alfa in respiratory distress syndrome - Reply
Ainsworth, S. B., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., & Mathews, J. N. S. (2000). Pumactant and poractant alfa in respiratory distress syndrome - Reply. LANCET, 356(9231), 766. doi:10.1016/S0140-6736(05)73664-3
Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial
Ainsworth, S. B., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., Matthews, J. N. S., Fenton, A. C., & Platt, M. P. W. (2000). Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial. LANCET, 355(9213), 1387-1392. doi:10.1016/S0140-6736(00)02136-X
A Review of Outcome of Babies with Congenital Diaphragmatic Hernia
Beresford, M. W., & Shaw, N. J. (2000). A Review of Outcome of Babies with Congenital Diaphragmatic Hernia. Pediatr Pulmonol, 30(3), 249-256.
Poractant alfa and pumactant for treatment of respiratory distress syndrome in neonates born at 25 to 29 weeks¿ gestation: a randomised trial
Ainsworth, S., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., Matthews, J. N. S., Fenton, A. C., & Ward Platt, M. P. (2000). Poractant alfa and pumactant for treatment of respiratory distress syndrome in neonates born at 25 to 29 weeks¿ gestation: a randomised trial. Lancet, 355(9213), 1387-1392.
Pumactant and poractant alfa in respiratory distress syndrome. Correspondence
Ainsworth, S., Beresford, M. W., Milligan, D. W. A., Shaw, N. J., & Matthews, J. N. S. (2000). Pumactant and poractant alfa in respiratory distress syndrome. Correspondence. Lancet, 356, 765-766.
Randomised controlled trial of patient triggered and conventional fast rate ventilation in neonatal respiratory distress syndrome
Beresford, M. W., Shaw, N. J., & Manning, D. (2000). Randomised controlled trial of patient triggered and conventional fast rate ventilation in neonatal respiratory distress syndrome. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 82(1), F14-F18. doi:10.1136/fn.82.1.F14